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ABSTRACT 
Tumor cells are well known to exhibit ER stress as a result of their altered environment 
characterized by redox and calcium imbalance, deregulation of protein synthesis to meet 
their oncogenic demands, and decreased vascularization associated with nutrient limitation 
and hypoxia, all of which are conducive of ER stress. Accordingly, markers of ER stress 
signaling response are up-regulated in various cancers. The outcome of ER stress signaling 
response varies from survival and adaption to apoptosis. Although pro-apoptotic ER stress 
signaling molecules are up-regulated in cancer, the mechanisms by which cancer cells seem 
refractory to, or evade, their apoptotic signaling are not fully understood. In this study, we 
investigate roles of the mammalian Ecdysoneless (ECD) in ER stress and oncogenesis. 
Certain tumors overexpress ECD protein suggesting possible roles in oncogenesis.  In fact, 
both normal and cancer cells require ECD for their growth and undergo cell cycle arrest 
when the ECD level is deficient. ECD associates with various stress response proteins such 
as p53, well known for genotoxic stress response such as DNA damage, and TXNIP, an 
oxidative stress protein recently implicated in ER stress response. Furthermore, ECD is a 
critical component of chaperone-like complexes such as the R2TP complex whose 
members have ER stress-related roles. In this study, we provide evidence that ECD is 
involved in ER stress. 
 Stress induction by multiple stimuli, including Thapsigargin, Tunicamycin, glucose 
starvation, H2O2, NOX4 overexpression, led to reduced ECD protein levels, but ECD 
mRNA increased, in a PERK-eIF2α dependent manner. Although a phospho-protein, ECD 
is not a target for a phosphorylation-mediated degradation by PERK but is rather targeted 
for a translation block via the PERK-eIF2α axis. To assess the functional connection 
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between ECD and ER stress signaling pathways, we used cells in which ECD could be 
inducibly depleted or overexpressed. Depletion of ECD enhanced PERK signaling and 
apoptosis upon ER stress induction while overexpression of ECD produced the opposite 
effect by inhibiting PERK signaling and increasing cell survival. IRE1α signaling was 
slightly affected by these changes in the cellular level of ECD, as indicated by the slight 
increase or decrease of its downstream target, spliced XBP-1, upon ER stress induction in 
the presence or absence of ECD; on the other hand, the ATF6 pathway was minimally 
affected. 
Based on these findings, we examined the possible mechanism by which ECD regulates 
ER stress signaling, particularly the PERK pathway. We found that ECD co-localized and 
associated with all the ER stress sensors PERK, IRE1α, ATF6 and GRP78. However, ECD 
does not modulate the enzymatic activity of PERK toward its substrate eIF2α. Rather, ECD 
enhanced chaperones’ levels, predominantly, GRP78 upon ER stress induction. Finally, 
disruption of this chaperone-enhancing effect of ECD abrogated the attenuating effect of 
ECD on PERK and impaired the pro-survival effect of overexpressed ECD upon ER stress 
induction. Taken together, ECD regulates the levels of chaperones, predominantly, GRP78 
to enhance the folding capacity of the stressed ER and provide survival advantage in a 
stress condition. 
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CHAPTER ONE: INTRODUCTION 
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1.1 Overview of the Endoplasmic Reticulum (ER) and its functions in the cells 
 
The Unfolded Protein Response (UPR), a term used interchangeably with 
Endoplasmic Reticulum (ER) stress response, is a reference to stress in the ER which is a 
membrane-bound sub-cellular organelle interconnecting other organelles (1), including 
the Golgi apparatus, the lysosome, the mitochondria and the nucleus. It is the largest 
organelle and the site for many central cellular functions such as synthesis, folding and 
maturation of secreted and membrane proteins, biogenesis of cholesterol, and calcium 
storage.  Different classes of proteins mediate these functions of the ER; key among them 
are proteins involved in translation.  In eukaryotic cells, translation occurs directly in the 
ER, following assembly and translocation of the ribosomal complex to the translocation 
channel. This complex is composed of the eukaryotic initiation factor 2 alpha (eIF2a) in a 
ternary complex with bound GTP and the methionine initiator tRNA (Met-tRNAi-eIF2a-
GTP) (2). As the newly synthesized proteins enter the ER, they undergo post-translational 
modifications (PTM) in an oxidative environment. Examples of common PTM are 
glycosylation, disulfide bond formation and phosphorylation. Proper PTM precedes 
proper folding of proteins into their three-dimensional structure with the assistance of ER 
resident chaperones such as the Glucose-Regulated Protein 78/ Immunoglobin Binding 
Protein (GRP78/ Bip), GRP94, calreticulin, calnexin and protein disulfide isomerases or 
PDI (3). The PDIs, in particular, are oxygen-requiring ER oxidoreductase 1 (Ero1) 
enzymes which generate disulfide bonds de novo and transfer them to their thioredoxin 
motif containing the thiol/disulfide oxidoreductase site (4). Lastly, the ER chaperones are 
calcium binding proteins and function calcium-dependently, justifying why the ER is also 
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the main calcium storage in the cell, with ATP-dependent calcium pumps which influx 
calcium from the cytosol to the ER. The ER also participates in intra and extracellular 
calcium signaling (5).  
 
 
1.2 Physiological and pathological conditions that perturb ER homeostasis and 
induce stress  
Physiological conditions that induce stress in the ER, such as glucose deficiency, 
are cell type specific. Glycosylation, a critical PTM, is disrupted when cells are glucose-
deprived, as a result of a decreased level of glycosyl group in the cells (6). Moreover, 
glucose deficiency also decreases ATP level in the cells, impairing crucial functions of 
ATP-dependent calcium pumps in the cells (6). High glucose also perturbs proper ER 
function in secretory cells, such as pancreatic beta cells, due to the ensuing increased 
production of insulin that must be processed through the ER.  Other physiological 
perturbants that induce ER stress are calcium deprivation, which impairs the function of 
key ER chaperones, free fatty acids and cytokines. In pancreatic beta cells, the best model 
for studying ER stress, ER stress can be physiologically induced by mutant insulin (6). 
Thus, pathological conditions that cause increased blood glucose levels, such as diabetes, 
induce ER stress (7). Viral infection is another type of pathological ER stress inducer 
because of the increased synthesis of viral proteins that must be processed in the host ER. 
Ischemia, the loss of blood supply to body organs, is also known to induce ER stress (8). 
Finally, in order to support proper protein folding, the ER environment is highly 
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oxidative and is sensitive to change in the reduction-oxidation (RedOx) state of the cell 
(9). 
1.3 Upstream signaling pathways of the ER stress response 
 
ER stress is a condition in cells characterized by protein load in the ER exceeding 
the folding capacity of the ER. It can be caused by any of the physiological or 
pathological conditions mentioned above. Additionally, pharmaceutical agents such as 
Thapsigargin, Tunicamycin, Brefeldin A, Dithiothreitol and hydrogen peroxide also 
induce ER stress. Perturbation of the ER function elicits a response termed the unfolded 
protein response (UPR). The UPR is an adaptive pro-survival response in its initial phase 
but shifts to a pro-apoptotic response when the stress becomes overwhelming (10-12). 
Three canonical pathways mediate these two phases of the UPR of which PERK (PKR-
like ER Kinase), IRE1α (Inositol Requiring Enzyme 1 alpha) and ATF6 (Activation of 
Transcription Factor 6) are the upstream players.  
PERK is an ER transmembrane kinase with luminal, transmembrane and 
cytoplasmic domains. The cytoplasmic c-terminal kinase domain of PERK is activated by 
homo-dimerization of the protein followed by auto-phosphorylation (10,13,14). The 
active PERK kinase phosphorylates the eukaryotic initiation factor 2 alpha (eIF2a) (15), 
altering its conformation and leading to a gradual disassembly of the ternary Met-tRNAi-
eIF2a-GTP complex, a critical part of the active translation complex. The resulting 
inhibition of the translation machinery causes a decrease in the load of protein entering 
the ER lumen (15) as well as cell cycle block, allowing cells time to solve the stress in 
the ER. Although global cap-dependent translation is blocked, a cap-independent 
translation of specific ER stress response genes proceeds. One such cap-independently 
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translated protein is Activation of Transcription Factor 4 (ATF4) (15), a transcription 
factor of the same family as ATF6. ATF4 translocates into the nucleus to activate a 
transcription enhancer gene, the CCAAT-enhancer-binding protein homologous protein 
(CHOP), which sensitizes cells to ER stress-induced cell death by multiple mechanisms 
including a down-regulation of the pro-survival Bcl-2 (B-Cell Lymphoma 2) protein 
family while increasing levels of members of the death receptor protein family. 
Moreover, CHOP is known to down-regulate glutathione levels, the cell’s anti-oxidant 
defense protein, leading to a surge in the levels of reactive oxygen species (ROS), a 
subsequent release of cytochrome c into the cytoplasm and activation of the caspase 
cascade, culminating in cell death (15-19). Concurrently, CHOP activates another 
protein, GADD34 which, together with the type 1 protein phosphatase  (PP1), targets 
eIF2α for de-phosphorylation and resumption of protein synthesis (20-24). Alternatively, 
this recovery from the stress-induced translation block is also achieved in cells by cellular 
PERK inhibitor p58 IPK (25,26).   
IRE1 exists in two isoforms, IRE1α and IRE1β. IRE1α, the widely studied 
isoform, has both kinase and RNAse function. Like PERK, it is activated by dimerization 
and auto-phosphorylation. With the RNAse activity, it is known to splice a 26 nucleotide 
intron from the X-box binding protein 1 (XBP-1) (16,27-30) to generate an active 
transcription factor, which translocates to the nucleus to activate ER response genes, one 
of which is the ER degradation-enhancing protein (EDEM) (16,31). In severe ER stress, 
EDEM activates the massive degradation of misfolded and unfolded proteins, termed ER-
associated degradation (ERAD) (32,33), a process involving ER chaperone-mediated 
retro-translocation of proteins to the cytoplasm for proteasomal degradation. The RNAse 
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function of IRE1α is also associated with a degradation of ER-associated mRNA in a 
process termed RIDD or regulated IRE1α-dependent decay (34,35) to further inhibit 
protein translation into the stressed ER. With the kinase function, IRE1α is known to 
recruit TRAF2 (TNF-receptor activating factor 2) to activate the apoptosis-signaling 
kinase 1 (ASK1) and the Jun N-terminal Kinase (JNK), leading to caspase cascade and 
cell death (11,36). 
ATF6, like IRE1, exists in two isoforms, ATF6α, the most studied isoform, and 
ATF6β. Upon ER stress signaling, ATF6α translocates to the Golgi apparatus where it is 
proteolytically cleaved by the Golgi Site 1 & 2 proteases (SP 1&2) (37,38) to generate an 
active transcription factor which translocates into the nucleus to activate ER stress target 
genes. ATF6α activates expression of chaperones upon ER stress, including GRP78, 
GRp94 (39).  
 
1.4 The ER stress in Cancer: a paradox 
 
The ER stress is the basis of diseases collectively referred to as ER stress diseases, 
including heart diseases, neurodegenerative diseases, diabetes and cancer (40). With regard 
to cancer, the ER stress response is known to promote survival mechanisms in cancer, 
hence driving oncogenesis. The tumor microenvironment is indeed a very hostile 
environment, characterized by Redox imbalance (41,42)], deregulated protein synthesis 
(43), and decreased vascularization associated with hypoxia and hypoglycemia (44), all of 
which are conducive to ER stress. Cancer cells also generate a higher level of hydrogen 
peroxide, a precursor of reactive oxygen species (ROS) which also perturbs ER 
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homeostasis. As such, markers of the ER stress response are up-regulated in various 
cancers [22], suggestive of fully activated and operational ER stress signaling to drive 
tumor progression. For instance, X-Box binding Protein 1(XBP1) promotes survival in 
triple negative breast cancer by enhancing the hypoxic response pathway (45) while CHOP 
drives hepatocellular oncogenesis by promoting oncogenic cell growth (46). In the same 
vein, the chaperone GRP78 promotes tumor survival, metastasis, angiogenesis and 
resistance to a wide variety of therapies (47,48).  
Controversially, components of the ER stress response are also implicated in 
negative regulatory control of tumor growth.  In this context, activated PERK has been 
known to induce proliferation block via multiple mechanisms including blocks in DNA 
synthesis and protein translation (49-53). Moreover, expression of PERK  leads to tissue 
atrophy in Drosophila melanogaster, a phenotype that was corrected by co-expressing 
GADD34, the phosphatase that represses PERK signaling (54). Although there are 
conflicting reports as to the role of PERK in tumor progression, the PERK pathway has a 
strong potential to reduce the growth of tumor cells (55).  Besides PERK, a second 
possibility exists for the ER stress signaling to regulate tissue growth through ATF4 
which has also been shown to negatively control neurogenesis in the developing mouse 
brain (56). ATF4 levels change during cell cycle progression and the protein undergoes a 
phosphorylation-dependent degradation required for cell cycle progression (56). This 
negative regulatory role of ATF4 on cell growth was observed in another study in which 
overexpression of ATF4 inhibited cell proliferation and mammary gland development 
(57). 
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The last and third level of negative regulation of cell growth by components of the 
ER stress response involves CHOP, also known as Growth Arrest and DNA-Damage 
inducible (GADD153). Induction of CHOP has been reported in in vitro differentiation 
experiments of 3T3-L1 cells to adipocytes, a process requiring growth arrest (58), 
suggesting a connection of CHOP to growth arrest as indicated by the very nomenclature 
of the protein (Growth Arrest and DNA-Damage inducible). Moreover, in tumors of 
adipose tissue, a chromosomal translocation has been found to cause a fusion protein 
between  CHOP and a novel RNA binding protein, TLS (translocated in liposarcoma) 
(59-61). The TLS-CHOP fusion protein was oncogenic (62). This oncogenic gain of 
function of the mutant form of CHOP, ie TLS-CHOP, further implies an anti-oncogenic 
or growth suppressive role of the wild type CHOP. In fact, microinjection of CHOP into 
cells inhibited BrdU incorporation and caused proliferative block, a defect reversed by 
the TLS-CHOP variant mentioned above (62). Altogether, these studies provide strong 
evidence that the ER stress signaling has the capacity to both negatively and positively 
affect tumor growth. However, paradoxically, although the ER stress signaling is 
activated in various cancers, cells in tumors seem refractory to its growth inhibitory 
signaling and only proliferate, even indefinitely. This seeming tolerance of tumor cells to 
the stress-induced growth inhibitory signaling hints to the existence of mechanisms to 
desensitize and protect tumor cells against the growth inhibitory effect of the ER stress 
signaling. 
 
1.5 The Ecdysoneless (ECD) protein, its oncogenic and stress-related potentials  
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 ECD was first identified in Drosophila as the mutation that caused a deficiency in 
the steroid hormone, Ecdysone, a hormone that plays roles in normal embryogenesis, 
metamorphosis and reproduction (63), all of which require cell growth and proliferation. 
As a result, these ECD mutants understandably exhibited developmental defects. The 
mammalian ECD was discovered from a screen of genes that could rescue the growth 
defects in S. Cerevisiae mutant for the Growth Control Regulatory gene 2, GCR2 
(64).This was the first indication that the mammalian ECD plays a role in growth. Studies 
from my mentor’s lab provided the most direct evidence that ECD does indeed play a key 
role in positively regulating cell growth and development. The lack of ECD in cells 
caused cell cycle to be arrested in G1 phase, a defect that was rescued by exogenously 
expressed ECD (65). The requirement of ECD for cell growth may justify its over-
expression in various cancers and its association with poor prognosis and short patient 
survival (66,67). In pancreatic cancer, knock down of ECD reduced proliferation and 
tumorigenicity with cells arrested at G1-S phase (66). While ECD overexpression alone 
did not accelerate cell proliferation, its overexpression together with Ras enhanced cell 
proliferation in epithelial cells did (68). However, ECD overexpression in fibroblasts 
cells induced p53 dependent cellular senescence, by p53 stabilization and positively 
regulatingp53(69), implying a link to p53. Moreover, ECD interacts with p53 to stabilize 
it and positively regulates its transcriptional activity (69), raising the possibility that ECD 
may have a connection to p53 pathways. In addition to its tumor suppressive roles, p53 is 
also related to stress such as genotoxic stress and oxidative stress. ECD may be part of 
protein complexes that modulate p53 stress functions such as the oxidative stress 
regulator TXNIP. ECD interacts with TXNIP and together, ECD-TXNIP increases p53 
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activity (70). Similar to ECD, TXNIP interacts with p53 to increase its stability and 
function under oxidative stress (71). Significantly, a recent study found an ER-stress-
related role for TXNIP in its interaction with PDI (Protein Disulfide Isomerase) to 
increase their enzymatic activity during ER stress thereby reducing stress (72). 
Furthermore, TXNIP is implicated in ER stress response as a novel component of the 
stress response signaling to mediate the inflammation-related axis of the stress-induced 
apoptosis (73). Also, TXNIP may also regulate the physiological function of the ER 
because it is part of the cellular redoxisome, comprising Thioredoxin, which regulates the 
redox state of the cell including the redox environment in the ER. The PDIs mentioned 
above are redox-sensitive ER oxidoreductases with Thioredoxin motifs and changes in 
the ER oxidative environment impair their functions (4).  
Lastly, we and others have recently shown that ECD associates with R2TP 
complex (74,75). The R2TP complex is involved in the assembly and remodeling of large 
protein-protein or protein-RNA complexes, such as RNA polymerase, small nucleolar 
ribonucleoproteins (snoRNPs), and phosphatidylinositol 3-kinase-related kinases 
(PIKKs) (76). Our recent study showed that the N-terminal region of ECD associates 
with the RUVBL1 component of the R2TP complex and both the phosphorylation and 
interaction of ECD with RUVBL1 are required for ECD’s role to promote cell cycle 
progression (75). The R2TP has an ER stress-related role through its RUVBL2 
component (77). Notably, RUVBL2, or TIP49b has been shown to inhibit the activity of 
ATF2 (77), a downstream target of PERK signaling, suggesting a role of the R2TP 
complex component in ER stress. Overall, the multiple lines of evidence presented above 
24 
 
 
 
suggest some connection of ECD to ER stress. In my thesis, I investigated in detail 
whether ECD regulates ER stress. 
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2.1 Overview 
The mammalian Ecdysoneless (ECD) is a highly-conserved ortholog of the Drosophila 
ECD gene product whose mutations impair the synthesis of Ecdysone and produce cell-
autonomous survival defects but mechanisms by which ECD functions are largely 
unknown. This study presents evidence that ECD regulates endoplasmic reticulum (ER) 
stress response. Stress induction by multiple stimuli, Thapsigargin, Tunicamycin, glucose 
starvation, H2O2, NOX4 overexpression, DTT, and sorbitol, led to reduced ECD protein in 
levels in multiple cell lines (MCF7, MDA-468, MCF10A, Panc-1, 76NTERT, MDA231-
NOX4). However, contrary to the decrease in ECD protein levels, ECD mRNA increased 
upon Thapsigargin treatment suggesting that the decrease in ECD protein is not at 
transcriptional level. To elucidate the ER stress signaling pathway regulating ECD protein 
levels, we induced ER stress in MEF cells in which the three ER stress pathways, PERK, 
IRE1α and ATF6, had been individually abrogated to produce single knock out (KO) 
MEFs. In IRE1α KO and ATF6 KO MEFs, the decrease in ECD protein levels was 
comparable with the control WT MEFs upon ER stress induction. However, in PERK KO 
MREFs, the levels of ECD protein did not change upon ER stress induction as compared 
to WT PERK. Furthermore, in PERK KO MEFs, ECD mRNA levels failed to increase, 
suggesting that the decrease in ECD protein and the increase in ECD mRNA may be tied 
to PERK activity. Since ECD is a phospho-protein and certain proteins undergo a 
phosphorylation-dependent degradation, we first tested the hypothesis that the decrease in 
ECD protein levels is PERK phosphorylation mediated. To assess that possibility, we 
performed an in vitro kinase assay to examine the potential that ECD could be a substrate 
for phosphorylation by PERK, a kinase. However, we did not find that ECD was 
phosphorylated by PERK. The second hypothesis for the decrease in ECD protein levels 
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was that ECD protein translation was blocked by PERK phosphorylation of eIF2α. To test 
that hypothesis, we induced ER stress in phospho-deficient eIF2α MEFs and found that the 
decrease in ECD levels upon ER stress induction was abrogated just as in PERK KO 
MEFS. The results suggested that ECD protein levels are reduced via the PERK-eIF2α axis 
of the ER stress signaling and that ECD may be functionally linked to that PERK-eIF2α 
axis. To examine that possibility, we resorted to cells in which ECD could be inducibly 
depleted or overexpressed. Depletion of ECD increased the levels of p-PERK, p-eIF2α, 
and these effects were enhanced upon ER stress induction by Thapsigargin treatment or 
glucose deprivation along with an increase in CHOP mRNA, and cleaved caspase 3. A 
slight increase in the levels of spliced XBP-1, the downstream target of IRE1α, was also 
observed but cleaved ATF6 did not significantly change. These effects correlated with a 
decrease in the colony formation of the ECD-null cells. Reciprocally, overexpression of 
ECD led to a marked decrease in p-PERK and its downstream targets, p-eIF2α, ATF4 and 
CHOP mRNA levels. Spliced XBP1 levels were slightly decreased while ATF6 did not 
change significantly. These effects correlated with a decrease in caspase 3 cleavage and an 
increase in the colony forming ability of the ECD overexpressing cells. Taken together, 
these results suggested that ECD functions as a repressor of stress signaling, particularly 
as a negative regulator of PERK signaling and that ECD and PERK are linked through a 
negative feedback mechanism whereby ECD inhibits PERK while, when activated, PERK 
inhibits ECD protein by blocking its translation. 
Based on the findings presented above, we sought to investigate the possible mechanisms 
by which ECD regulates ER stress signaling, particularly the PERK pathway. First, we 
examined the localization of ECD relative to the upstream mediators of the ER stress 
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signaling and found that ECD localized and associated with PERK, ATF6, IRE1α and 
GRP78. To assess whether ECD directly regulates PERK signaling, we performed in vitro 
kinase assay of PERK with eIF2α in the presence of an increasing concentration of the 
ECD protein. However, ECD did not modulate enzymatic activity of PERK toward eIF2α. 
Since induction of chaperones during ER stress signaling is well known as a homeostatic 
mechanism aimed at restoring the ER function by clearing the stress stimulus, we next 
examined the effect of ECD on levels of chaperones, particularly GRP78 which is the major 
regulator of PERK signaling. We found that the levels of GRP78 (GRP94 and PDI to a 
lesser extent) were dependent on ECD and that depletion or overexpression of ECD 
decreased or increased GRP78 protein levels, respectively, upon ER stress induction. 
However, GRP78 mRNA was not affected, suggesting a post-translational effect. To 
determine whether a change in the levels of ECD affects GRP78 protein stability, we 
deleted ECD followed by cycloheximide treatment and found that the decrease in GRP78 
protein level was faster in ECD-null cells. Reciprocally, in ECD overexpressing cells, the 
decrease in the levels of GRP78 protein was slower upon cycloheximide treatment. Finally, 
to determine whether GRP78 was required for ECD effects on PERK signaling, we 
knocked down GRP78 and found that even in the presence of overexpressed ECD, a knock 
down of GRP78 abrogated the attenuating effect of ECD on PERK, correlating with a 
decrease in colony formation of the ECD overexpressing cells. Taken together, these 
results argue that ECD enhances the levels of chaperones, predominantly, GRP78 to 
enhance the folding capacity of the stressed ER and reduce stress. 
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2.2 INTRODUCTION 
 The endoplasmic reticulum (ER) is a central subcellular organelle with essential roles in 
the synthesis, folding and maturation of secreted and membrane proteins, biogenesis of 
cholesterol, calcium homeostasis and regulation of survival and apoptosis pathways (1-10). 
Aberrations in these ER functions are sensed by well-conserved ER transmembrane 
sensors, Inositol-Requiring Enzyme 1 alpha (IRE1α), PKR-like ER kinase (PERK) and 
Activating Transcription Factor 6 (ATF6), that activate homeostatic signaling pathways 
collectively referred to as the unfolded protein response (UPR) (11,12). These ER stress 
sensors exhibit a dynamic and reversible interaction with the ER chaperone GRP78 (13). 
In un-stressed cells, GRP78 is bound to luminal domains of UPR sensors, which maintains 
them in an inactive state (14). During ER stress, the increased load of unfolded proteins 
competes for GRP78 binding, leading to activation of UPR sensors (15). 
As an important chaperone, the level of GRP78 is also increased during ER stress 
signaling, mainly via the ATF6 pathway (16). The induction of GRP78 and other 
chaperones such as GRP94 (17-19) and PDI (20,21) is a homeostatic mechanism to 
restore normal functions in the ER and protect cells from stress-induced cell death. Part 
of GRP78’s cyto-protective role involves its regulation of the ER stress sensors during 
stress signaling to prevent their hyper-activation and ensuing cell death. To achieve that 
effect, GRP78 is known to reversibly bind the ER stress sensors, when induced, and 
inhibit their signaling (13). Consequently, overexpression of GRP78 has been shown to 
inhibit PERK signaling, in particular (13). Furthermore, GRP78 has been shown to 
physically interact with caspases (22) and prevent their cleavage (23).   
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The GRP78 protein is known to contain the canonical KDEL ER retention signal 
(24,25) which allows it to be retro-transported from the Golgi to the ER during its 
journey through the secretory pathway. Accordingly, GRP78 was traditionally thought of 
as an ER-resident protein. However, recent evidence points to a ubiquitous nature of the 
protein in cells. GRP78 has been found in the cytoplasm where it interacts with 
cytoplasmic proteins such as caspace-7 and clusterin protein (22,26); there is also 
evidence of GRP78 presence in the nucleus and mitochondria (27). This ubiquitous 
nature of GRP78 in cells suggests that the ER functions of GRP78 may not necessarily 
require its ER- localization, especially as studies have identified a cytoplasmic, non-
KDEL containing variant of the GRP78 protein which still has ER stress-related 
functions via cytoplasmic regulators of the ER stress signaling (28).  
   The PERK pathway has emerged as a key pathway in cellular UPR response as well 
as homeostasis under unstressed conditions and in disease states (29-34). Release of 
GRP78 from PERK leads to its dimerization, auto-phosphorylation and activation 
(15,35,36). A major PERK substrate is the eukaryotic translation initiation factor 2 alpha 
(eIF2α) whose phosphorylation by PERK inactivates it leading to a block in general cap-
dependent protein translation and consequent decrease in the protein load entering the ER 
(37); concurrently, PERK signaling selectively enhances the cap-independent translation 
of specific mRNAs, such as Activating Transcription Factor 4 (ATF4) (37). ATF4 induces 
the expression of CCAAT/enhancer-binding protein-homologous protein (CHOP) which 
promotes apoptosis in response to stress (37-45). PERK-induced phosphorylation of eIF2α 
also inhibits cell cycle progression by reducing the levels of cyclins and hence cyclin-
dependent kinase 2 (CDK2) activity (46-48). Termination of PERK signaling, together 
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with de-phosphorylation of eIF2α, is required to re-initiate protein synthesis and resume 
the cell cycle. Thus, PERK-mediated UPR leads to a coordinated program of cellular 
protection and mitigation of stress. However, PERK also contributes to an alternate 
outcome through CHOP-mediated activation of a cellular death pathway to eliminate 
severely damaged cells (37-45). Mechanisms to fine-tune the outcomes of UPR pathways 
are important to mitigate the negative consequences of ER stress. This is of particular 
importance under conditions where cells experience ER stress as part of their physiological 
responses, such as antibody-secreting plasma cells or insulin-secreting pancreatic islet cells 
(49). We have identified ECD as a negative regulator of the PERK-mediated UPR. 
The ECD gene was first identified based on genetic mutations in Drosophila that lead to 
reduced production of the developmentally-regulated steroid hormone Ecdysone, which is 
synthesized in the ER, hence the designation of Ecdysoneless for such fly mutants (50). 
The mammalian ECD gene was cloned based on the rescue of growth defects in S. 
cerevisiae mutant in the growth control regulatory gene 2 (GCR2), a glycolysis regulatory 
gene (51). Thus, ECD was thought to be involved in mammalian glycolysis gene 
expression and initially named hSGT1 (human suppressor of gcr2)(51). My lab identified 
the same gene in a screen for interacting partners of human papilloma virus E6 oncoprotein 
and found it to interact with p53 and transactivate p53-regulated genes  (52,53). 
To elucidate the functional role(s) of mammalian ECD, my lab generated ECD-null mice 
and demonstrated that homozygous deletion of ECD was early embryonic lethal while ex 
vivo Cre-mediated deletion of ECD in ECDfl/fl mouse embryonic fibroblasts (MEFs) led to 
proliferative block and a significant decrease in cell survival (54,55). ECD was found to 
be essential for E2F target gene expression by facilitating the dissociation of the 
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retinoblastoma RB protein  from E2F and promoting the G1-to-S phase cell cycle 
progression (54). As a consequence, ECD-null MEFs showed a decrease in the levels of 
cyclins A, B1, E and D1, reduction in CDK2 kinase activity and were arrested in G1 phase 
of the cell cycle (54). Interestingly, E2F family proteins such as the E2F1 have been 
implicated in UPR-mediated cell death (56). In addition to its promotion of the G1/S phase, 
ECD also promotes G2/M phase of the cell cycle and its knockdown induced not just a 
G2/M arrest but also apoptosis (57). Induction of UPR not only induces apoptosis but also 
halts cell cycle progression in G1 and G2 phases (46-48,58) and these effects are mediated 
by PERK (46,47), suggesting a potential connection between ECD and the PERK arm of 
the UPR.  
More recently, we uncovered another mechanism by which ECD regulates cellular 
proliferation, through its interaction with RUVBL1 and PIH1D1 components of the 
prefoldin co-chaperone R2TP (55) which is involved in the assembly or remodeling of a 
number of protein and protein-RNA complexes to regulate many physiological processes 
(59-65). Recently, it was reported that knock down of the RUVBL1 component of the 
R2TP complex induced cell cycle block and ER stress (66). Furthermore, ECD has been 
shown to associate with the stress response protein Thioredoxin-Interacting Protein 
(TXNIP) (67) which is known to bind to the ER chaperone PDI (protein disulfide bond 
isomerase) to increase its enzymatic activity to relieve ER stress (20). Lastly, TXNIP was 
recently shown to be a novel component of the UPR and is regulated by the PERK pathway 
(68). Based on these multiple lines of suggestive evidence pointing to a potential role of 
ECD in the regulation of ER stress, we investigated ECD and demonstrated that it 
modulates ER stress signaling, particularly the PERK arm. Induction of ER stress, using 
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both chemical ER stress inducers (Thapsigargin and Tunicamycin) and physiological ER 
stress inducers (glucose starvation), led to a reduced level of the ECD protein, and this 
effect was not seen in PERK KO or phospho-deficient eIF2α MEFs. Notably, ECD mRNA 
levels were increased, suggesting impaired ECD translation as a mechanism for reduced 
protein levels. ECD depletion increased the levels of p-PERK and its downstream targets, 
p-eIF2α and CHOP mRNA while ECD overexpression markedly decreased their levels 
upon ER stress induction. Spliced XBP-1, the downstream target of IRE1α and cleaved 
AFT6 were slightly affected. Significantly, ECD overexpression and depletion distinctly 
affected the survival outcome of cells upon ER stress. Additionally, we found that the 
levels of GRP78 (GRP94 and PDI to a lesser extent) were dependent on ECD and that 
depletion or overexpression of ECD decreased or increased GRP78 protein levels, 
respectively, upon ER stress induction. However, GRP78 mRNA was not affected, 
suggesting a post-translational effect.  Deletion of ECD followed by cycloheximide 
treatment showed that the decrease in GRP78 protein level was faster in ECD-null cells. 
Reciprocally, in ECD overexpressing cells, the decrease in the levels of GRP78 protein 
was slower upon cycloheximide treatment. Finally, to determine whether GRP78 was 
required for ECD effects on PERK signaling, we knocked down GRP78 and found that 
even in the presence of overexpressed ECD, a knock down of GRP78 abrogated the 
attenuating effect of ECD on PERK, correlating with a decrease in the colony formation of 
the ECD overexpressing cells. Taken together, these results argue that ECD enhances the 
levels of chaperones, predominantly, GRP78 to enhance the folding capacity of the stressed 
ER and reduce stress. 
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2.3 MATERIALS AND METHODS 
 Reagents and antibodies 
 Thapsigargin, (Cat# 12758) and Tunicamycin (Cat# 12819) and Brefeldin A (cat# 9972) 
were from Cell Signaling and dissolved in DMSO. Dithiothreitol (cat# 9776), Sorbitol 
(cat# 1876) and Hydrogen Peroxide (cat# H1009) were from Sigma. A monoclonal 
antibody against ECD, generated in our laboratory, has been described previously (69). 
Antibodies against p-PERK (cat# 3179), ATF4 (cat# 11815), p-eIF2α (cat# 9721), eIF2α 
(cat# 9722), Caspase 3 (cat# 9662), s-XBP1 (cat# 12782), IRE1α (cat# 3294), GRP78 (cat# 
3177), p-SAPK/JNK (cat# 9251) and total PERK (cat# 3192) were from Cell signaling. 
ATF6 antibody was purchased from Enzo Life (cat# ALX-804-381-C100).  
 
 
  
 Cell lines and culture conditions 
ECD inducible MEFs were generated from the lab. 13.5 days old embryos of mice of the 
genotype Tet(O)-Flag-hECD-IRES-eGFP were used. rtTA was introduced retrovirally to 
generate Tet(O)-Flag-hECD-IRES-eGFP; rtTA.  ECD fl/fl MEFs were maintained in 
DMEM medium supplemented with 10% fetal bovine serum and treated with adenoviruses 
coding for GFP (adeno-GFP, control) or Cre (adeno-Cre) as described previously (54,55). 
The culture condition for the ECD inducible MEFs was same as the ECD fl/fl MEFs. Panc-
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1 cells have been previously described (70). For ECD overexpression studies, control 
MEFs or ECD over-expressing MEFs were cultured with 1μg/ml of Doxycycline (Cat # 
231286, BD Biosciences) to induce expression of the ECD transgene. MEFs with a non-
phosphorylatable eIF2α were obtained from Dr. Thomas Rutkowski’s lab, Carver College 
of Medicine, Iowa and has been described elsewhere (71). PERK knockout (KO) MEFs 
were from ATCC (CRL-2976) while IRE1α KO and ATF6 KO were gifts from Dr. Urano’s 
lab, Washington University St. Louis and Dr. Hendershot’s lab, St. Jude Children Research 
Hospital, Tennessee, respectively.  Immortal mammary epithelial cell lines MCF-10A, 
76NTERT were from the lab and was cultured in DFCI-1 medium (55). Cancer cells line 
MCF7 and MDA-468 were cultured in alpha media. NOX4 expressing MDA-231 were 
obtained from Dr. Teoh-Fitzgerald’s lab (UNMC, Biochemistry). 
 
Western blotting 
For western blotting, cell lysates were prepared in RIPA buffer (Cat# 89901, Thermo 
Scientific) supplemented with protease inhibitors (Roche, Cat# 11836145001). Lysates 
were resolved on SDS-PAGE gel, transferred on to nylon membrane (IPVH00010, 
Millipore), and subjected to ECL-based Western blotting as described (54,55). 
Colony Formation Assay- For clonogenic assay, 1,000 cells were plated in triplicate and 
allowed to attach to the plate (about 8 h) followed by treatment with Thapsigargin for 24h. 
10 days later, colony formation was assessed as previously described (54,55). 
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In vitro kinase assay-A total of 500 ng of purified recombinant ECD proteins or its 
mutants was incubated with 0.2 mM ATP, 1 µCi of [32P]ATP (Perkin-Elmer), and 0.2 µl 
(10 U) of human recombinant PERK or CK2 (NEB, Beverly, MA) at 30°C for 30 min. 
The reaction was stopped by adding SDS-PAGE sample buffer. The 32P-labeled proteins 
were detected by autoradiography after SDS-PAGE and then transfer to polyvinylidene 
difluoride (PVDF) membranes (Millipore). 
 
Induction of ER stress by glucose starvation- Panc-1 cells were maintained in DMEM 
supplemented with 10% fetal bovine serum and then switched to glucose-free DMEM 
medium (cat# 11966-025, life technologies) for indicated times. 
 
Statistical analysis- for assessment of statistical significance, a Student t test was used. P 
values of < 0.05 were considered statistically significant 
 
 
RNA isolation and real-time quantitative PCR (qRT-PCR) 
 Total RNA was isolated using the TRizol reagent (Invitrogen cat# 15596018). 1 µg of 
RNA was reverse- transcribed using SuperScript TMII reverse transcriptase (Invitrogen 
cat# 18064014). The qPCR was performed with primer sets indicated in the table 
belowbelow:  
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Gene Forward primers Reverse primer 
Mouse 
CHOP 
CTGCCTTTCACCTTGGAGAC CGTTTCCTGGGGATGAGATA 
Huma
n 
CHOP 
CATTGCCTTTCTCCTTCGGG CCAGAGAAGCAGGGTCAAGA 
Mouse 
ECD 
CCGGTCTGGCACAAACTTCTGC
TG 
AGGGTCGAAGCATCCCTCCATC
GA 
Huma
n 
ECD 
ACTTTGAAACACACGAACCTGG
CG 
TGATGCAGGTGTGTGCTAGTTC
CT 
Mouse 
GRP7
8 
AGTGGTGGCCACTAATGGAG CAATCCTTGCTTGATGCTGA 
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2.4 Results 
2.4.1 Effect of ER stress induction by Thapsigargin, Tunicamycin, Brefeldin A on 
ECD protein levels in MCF-7, MDA-468 and MCF-10A 
To begin to explore the potential link of ECD to stress pathways, we assessed the effects 
of various chemical ER stress inducers on ECD protein levels. For this purpose, cancer 
cell lines MCF7 and MDA-468 and normal mammary epithelial cell line MCF-10A were 
treated with Thapsigargin, Tunicamycin and BFA, and ECD protein levels were analyzed 
by western blot. Treatment with either chemical increased the levels of eIF2α 
phosphorylation, a marker of ER stress (Figure 2.1A-C). ECD protein levels did not 
change much in MCF7 and MDA-468 cells with either chemical but the levels decrease 
more dramatically in MCF-10A (Figure 2.1 A-C)  
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Figure 2.1 Effect of ER stress induction in MCF7, MDA-468 and MCF-10A: (A-C): 
indicated cells were treated with Thapsigargin (Tg), Tunicamycin (tun) and Brefeldin A 
(BFA) and equal protein was resolved on SDS-PAGE gel followed by western blot with 
indicated antibodies. 
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2.4.2 Physiological stress by glucose deprivation led to a decrease in ECD protein 
levels 
Given the effect of chemical ER stress inducers on ECD protein levels presented above, 
we next assessed whether physiological stress such as glucose starvation would have 
similar effects.  For this purpose, we used a human pancreatic carcinoma cell line (Panc-
1) and mouse beta cells (MIN-6) cells both of which are known to exhibit ER stress upon 
glucose starvation (21).  These cells were switched from their normal complete DMEM 
medium to glucose-free medium for various time points and ECD protein levels were 
assessed by western blot. This glucose-free culture condition increased the levels of the 
glucose-regulated protein 78 (GRP78), PERK phosphorylation (p-PERK) and p-eIF2α as 
expected (21). Significantly, similar to chemical ER stress, glucose starvation-induced 
ER stress also exhibited reduced levels of the ECD protein (Figure 2.2 A-B) 
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Figure 2.2: Physiological stress by glucose starvation reduces ECD protein levels: 
(A-B) Human pancreatic carcinoma and mouse beta cell lines were cultured in glucose-
free medium for indicated time points. Equal protein was resolved on SDS-PAGE gel 
followed by western blot with indicated antibodies. 
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2.4.3 Effects of other forms of stress on ECD protein levels 
 The effect of both chemically-induced and physiologically-induced stress on the levels 
of ECD protein prompted us to further examine the effects of other stresses (oxidative, 
osmotic, and reducing) on ECD protein levels. For that purpose, we first treated 
MCF10A, 76NTERT and MCF7 cells with H2O2, a commonly used oxidative stress 
inducer (72). Significantly, treatment with H2O2, also led to a decrease in ECD protein 
levels (Figure 2.3 A). To further assess these effects, we used another type of cells 
(MDA-231) which are under a physiologically-induced oxidative stress. These cells 
express the NOX4 system, which generates ROS and oxidative stress (73,74) as 
diagrammed in Figure 2.3 B. Again, here too, even in the absence of any exogenously-
derived stress, ECD protein levels are lower in the NOX4-expressing cells as compared 
to the control cells. Reductive and osmotic stresses, by DTT and sorbitol treatment, 
respectively, also led to a decrease in the ECD protein level (Figure 2.3 C-D). 
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Figure 2.3: Effects of other forms of stress (oxidative, reductive and osmotic) on 
ERCD protein level: (A) MCF-10A, 76NTERT and MCF7 cell lines were treated with 
indicated doses of  H2O2, (B) MDA-231 expressing NOX4 and their control cells were 
lysed, (C) MCF10A and MCF7 cell lines were treated with DTT, (D) T98G cells were 
treated with sorbitol. Equal protein was resolved on SDS-PAGE gel followed by western 
blot with indicated antibodies. 
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2.4.4 ER stress induction by Thapsigargin and glucose deprivation led to increase in 
ECD mRNA levels 
Given that all forms of stress led to a decrease in ECD protein levels, we assessed 
whether this decrease in ECD protein levels was due to reduced ECD mRNA levels.  We 
treated MCF10A cells with Thapsigargin and measured ECD mRNA levels using qRT-
PCR. Induction of CHOP mRNA was used as a control (Figure 2.4 A). Notably, ECD 
mRNA levels were not only not reduced but in fact showed an increase (Figure 2.4 B), 
suggesting that the reduction in the ECD protein level was not at the transcriptional level. 
Likewise, physiological stress by glucose starvation inPanc-1 cells also increased ECD 
mRNA levels (Figure 2.4 D) with GRP78 mRNA induction used as control (Figure 2.4 
C). 
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Figure 2.4: ER stress induction by Thapsigargin and glucose starvation led to an 
increase in ECD mRNA. MCF-10A cells were treated with Thapsigargin (A-B) and 
Panc-1 cells were cultured in glucose-free medium (C-D), then total RNA was isolated 
followed by qRT-PCR using primers against CHOP, GRP78, and ECD(Mean +/- SD and 
p-values are shown from 3 independent experiments * p<0.05). CHOP and GRP78 
mRNA induction served as control for Thapsigargin-induced and glucose starvation-
induced ER stress, respectively. 
 
 
 
  
56 
 
2.4.5 The decrease in the levels of ECD protein upon ER stress induction is PERK-
eIF2α dependent 
Given the results above that various stresses led to a decrease in ECD protein level but 
that ECD mRNA increased, we sought to determine the mechanism by which ECD 
protein and mRNA levels inversely correlate. All stresses mentioned above are 
interconnected. For instance, Oxido-reductive stress induces ER stress and vice versa, as 
summarized in the diagram in Figure 2.3B. ER stress activates three canonical signaling 
pathways summarized in Figure 1.1. To determine which pathway controls ECD protein 
and mRNA levels, we induced ER stress in cells in which the upstream mediators of the 
pathways (PERK, IREα and ATF6) have been genetically abrogated. For that purpose, 
we used ATF6 KO, IRE1α KO and PERK KO MEFs in which the pathways have been 
individually knocked out (KO). The absence of the protein was confirmed by western 
blot with antibody against the protein that was knocked out (Figure 2.5A-C). In ATF6 
KO and IRE1 KO MEFs, the decrease in ECD protein levels was comparable to that in 
the control wild-type (Figure 2.5A-B). However, in PERK KO MEFs, the decrease in 
ECD protein levels was abrogated (Figure 2.5C), suggesting that the decrease in ECD 
protein levels is PERK dependent.  
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Figure 2.5: The decrease in the levels of ECD protein upon ER stress induction is 
PERK dependent. (A-C): Wild-type (WT) ATF6, IRE1α, PERK and their knockout 
(KO) MEFs were treated with Thapsigargin and then cell lysates were resolved on SDS-
PAGE gels followed by western blot with indicated antibodies. 
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As we previously observed that ECD mRNA increased upon ER stress induction but the 
protein levels decreased, here we sought to assess whether ECD mRNA changes in 
PERK WT vs. KO MEFs.  Again, we treated PERK WT and KO MEFs with 
Thapsigargin and measured the change in ECD mRNA by qPCR. The identity of the 
PERK KO MEFs in this experiment was determined by analyzing the product of the PCR 
product obtained with primers against the PERK KO domain. As shown in Figure 2.6A, 
there was no PCR product in the PERK KO samples, confirming the identity of the cells. 
To further confirm that, we used primers against CHOP mRNA in the qPCR. As 
expected, while CHOP mRNA was induced in the PERK WT cells, the induction was 
very minimal in the PERK KO cells (Figure 2.6B), since CHOP is downstream of PERK 
(44). Significantly, while ECD mRNA increased in PERK WT MEFs, it did not increase 
much in PERK KO MEFs (Figure 2.6C). This result that ECD mRNA failed to increase 
when the protein levels didn’t change, suggests that ECD mRNA only increases when the 
protein levels are down, suggesting a feedback mechanism. 
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Figure 2.6: ECD mRNA levels failed to increase in PERK KO MEFs upon ER 
stress. (A): PCR was performed on RNA isolated from PERK WT and KO MEFs with 
primers against the KO domain. The PCR product was resolved on agarose gel. (B-C): 
PERK KO and control WT MEFs were treated with Thapsigargin and total RNA was 
isolated at indicated time points followed by qRT-PCR with primers against CHOP. 
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To explain the PERK-dependent decrease in ECD protein levels, we proposed two 
hypotheses: 
1) PERK phosphorylates ECD leading to ECD degradation since (i) PERK is a 
kinase,  (ii) ECD is a phospho-protein as a substrate for CK2 phosphorylation and 
(iii) certain proteins are known to undergo a phosphorylation-dependent 
degradation (75).  
2) PERK phosphorylates eIF2α to inhibit ECD protein translation since PERK is 
known to inhibit translation during ER stress signaling by phosphorylating eIF2α 
(37). 
To investigate the first hypothesis that ECD undergoes a PERK phosphorylation-
dependent degradation, we first assessed whether ECD could be a substrate for PERK 
phosphorylation by performing an in vitro kinase assay of ECD by PERK. EIF2α was 
used as the positive control for PERK phosphorylation since eIF2α is a substrate for 
PERK (37); and CK2 was used as a positive control for phosphorylation of ECD since 
CK2 is known to phosphorylate ECD (55). As expected, eIF2α and ECD were 
phosphorylated in vitro by PERK and CK2, respectively (Figure 2.7, lanes 1-2 and 3, 
respectively). However, a phosphorylation of ECD by PERK was not observed (Figure 
2.7, lane 4-5). 
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Figure 2.7: PERK does not phosphorylate ECD: In vitro kinase assay of  recombinant 
human ECD prepared from two different sources (bacterial and insect cell derived) was 
performed using human recombinant GST fused PERK. Proteins were separated by SDS-
PAGE, transferred to PVDF membrane, and phosphate labeling was detected by 
autoradiography. Phosphorylation of eIF2α by PERK was used as the positive control for 
PERK mediated phosphorylation while phosphorylation of ECD by CK2 was used as the 
positive control for ECD phosphorylation. 
p-ECD 
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To investigate the second possibility that ECD translation is blocked by PERK 
phosphorylation of eIF2α, we resorted to eIF2α MEFs. Since PERK activation and 
subsequent phosphorylation of eIF2α mediates translational block in response to ER 
stress (37), we utilized MEFs from mice that carry a serine 51 to alanine mutation in 
eIF2α which prevents its phosphorylation by activated PERK and makes the cells 
resistant to PERK-mediated translation block upon ER stress induction (71). As expected, 
the levels of p-eIF2α increased in WT MEFs but not in the phospho-deficient eIF2α 
mutant MEFs when ER stress was induced with Thapsigargin or Tunicamycin (Figure 
2.8, compare lanes 1-3 with lanes 4-6). Importantly, while ECD protein levels decreased 
in WT MEFs treated with ER stress inducers (Fig. 1J, compare lane 1 to lanes 2-3), the 
levels of ECD protein did not change in identically-treated mutant eIF2α MEFs (Figure 
2.8, compare lane 4 to lanes 5-6). Together, these results support a conclusion that ECD 
protein levels are downregulated upon ER stress in a PERK-eIF2α dependent manner, 
and that ER stress upregulates ECD mRNA levels, suggesting a regulatory link between 
ECD and the PERK pathway of ER stress. 
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Figure 2.8: The decrease in ECD protein levels is abrogated in eIF2α phospho-
deficient MEFs. WT eIF2α MEFs or mutant eIF2α phospho-deficient MEFs were treated 
with Thapsigargin (Tg, 50 nM) or Tunicamycin (Tun, 50 ng/ml) for 14 h and then cell 
lysates were analyzed by western blotting with indicated antibodies. 
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2.4.6 ECD depletion or over-expression distinctly regulate ER stress signaling upon 
ER stress induction  
The abrogation of the decrease and increase in ECD protein and mRNA levels, 
respectively, upon disruption of PERK pathway (Figure 2.5-2.8) suggested that ECD may 
be functionally linked to UPR through PERK pathway. Therefore, we assessed the 
activation of the PERK pathway in the absence or presence of UPR inducers in cells in 
which ECD could be inducibly deleted. For this purpose, we utilized ECDfl/fl MEFs which 
have been previously established and shown to exhibit ECD gene deletion and loss of ECD 
protein expression upon infection with adenovirus expressing Cre recombinase (54). 
Previously, it was observed that induction of ECD deletion in these ECDfl/fl MEFs, aside 
from inducing cell cycle arrest, led to a decrease in cell survival even in the absence of any 
stress (54,55).  
Notably, Cre-meditated deletion of ECD in the ECDfl/fl MEFs led to an increase in the 
levels of phospho-PERK (p-PERK) and p-eIF2α, when compared to control adeno-GFP 
infected MEFs (Figure 2.9 compare lane 1 with 3), and these effects were further enhanced 
by treatment with Thapsigargin (Tg), the inhibitor of the Sarco/Endoplasmic Reticulum 
Calcium ATPase (Figure 2.9, compare lane 2 with 4). Spliced XBP1, the downstream target 
of IRE1α signaling also showed some increase in ECD null cells upon Thapsigargin 
treatment while ATF6 did not show a significant change (Figure 2.9).  
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Figure 2.9: Increased UPR in ECD-null cells upon Thapsigargin. Ecd fl/fl MEFs were 
infected with adenoviruses coding for GFP (adeno-GFP for control) or Cre (adeno-Cre) for 
72h. The cells were then left untreated or treated with Thapsigargin. Equal amount of 
proteins was resolved on SDS-PAGE gel followed by western blotting with indicated 
antibodies. 
Tg:                 -                       +                          -                          + 
Lane:                   1                   2                       3                        4  
ECD 
p-PERK 
PERK 
p-eIF2α 
eIF2α 
ATF6(cleaved) 
XBP1(spliced) 
β-actin 
WT ECD-/- 
68 
 
 
Consistent with the increased p-PERK levels upon ECD deletion, Thapsigargin treated 
ECD-depleted MEFs also exhibited increased expression of CHOP mRNA (Figure 2.10A), 
a downstream effector of the PERK pathway whose target genes promote cell death (37-
41,43,44). The increased CHOP mRNA correlated with an increased cleaved caspases 3 in 
ECD null cells (Figure 2.10B, compare lane 2 with 4) and a significant reduction in cell 
survival, as measured by colony-forming assays (Figure 2.10C). 
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Figure 2.10: ECD-null cells exhibited increased ER stress and cell death upon 
Thapsigargin treatment. (A): After adenoviruses infection as described in Figure 2.9, 
cells were treated with Thapsigargin. Total RNA was isolated followed by qRT-PCR with 
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CHOP primers; Mean +/- SD and p-values from 3 independent experiments are indicated 
* p<0.05. (B): After Adenoviruses infection, the cells were then left untreated or treated 
with Thapsigargin. Equal amount of proteins was resolved on SDS-PAGE gel followed by 
western blotting with indicated antibodies.  (C): After adenoviruses infection as described 
in (A), equal number (1,000) of wild-type (WT) or ECD-/- cells were plated in triplicate 
and treated with Thapsigargin for 24h. 10 days later, surviving colonies were assessed after 
crystal blue (0.5% in 25% Methanol) staining. The color retained after the wash was 
dissolved in 10% acetic acid and the absorbance was read at 590 nm. The graph below 
represents the relative absorbance; Mean +/- SD and p-values from 4 independent 
experiments are indicated * p<0.05; ** p≤0.002 
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To further assess these effects, we used physiological stress in Panc-1 cells in which ECD 
was knocked down followed by glucose starvation. Again, here too,  a siRNA knock down 
of ECD plus glucose starvation led to an enhanced eIF2α phosphorylation, the downstream 
target of PERK, and increased cleaved caspase 3 as compared to control cells (Figure 2.11, 
compare lanes 1-5 with lanes 6-10), suggesting more cell death in ECD-knocked down 
cells upon glucose starvation. Moreover, spliced XBP-1 levels, the downstream target of 
IRE1α, were increased in ECD siRNA-treated cells as compared to the control cells 
whereas ATF6 levels were comparable (Figure 2.11, compare lanes 1-5 with lanes 6-10). 
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Figure 2.11: ECD knock down in Panc-1 cells upon glucose starvation led to increased 
UPR and cell death.  Panc-1 cells were treated with control or ECD siRNA for 48h. Then, 
the cells were switched to glucose-free media and cell lysates were prepared at indicated 
time points followed by western blot with indicated antibodies. 
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Given the effects of ECD depletion on the UPR presented above, we used a reciprocal 
approach to overexpress ECD and then examined its impact on the UPR, in particular the 
PERK pathway, upon ER stress induction. To this end, and because of ongoing difficulties 
overexpressing ECD in cancer cell lines, we resorted to MEFs generated in the lab from 
mice that carry a Doxycycline (Dox)-inducible ECD transgene ((Tet(O)-Flag-hECD-IRES-
eGFP; rtTA)) or a control transgenic mouse without rtTA ((Tet(O)-Flag- hECD-
IRESeGFP)). These MEFs were treated with Dox to induce ECD overexpression, followed 
by treatment with Thapsigargin. As expected, control MEFs exhibited an increase in p-
PERK and CHOP mRNA; however, the MEFs with Dox-induced ECD overexpression 
exhibited a substantially reduced level of p-PERK and CHOP mRNA upon Thapsigargin 
treatment as compared to control MEFs (Figure 2.12A-B).  
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Figure 2.12: Decreased p-PERK and CHOP mRNA induction in ECD inducible 
MEFs upon Thapsigargin. (A): ECD inducible MEFs [(Tet(O)-Flag- hECD-
IRESeGFP;rtTA)]  or control MEFs [(Tet(O)-Flag- hECD-IRESeGFP)] were treated with 
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Dox for 48 h followed by treatment with Thapsigargin. Cell lysates were prepared at 
indicated time points and equal amount of proteins was resolved on SDS-PAGE gel 
followed by western blot with indicated antibodies. (B): Following ECD induction and 
Thapsigargin treatment as described above, CHOP mRNA levels were assessed using 
qRT-PCR. 
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Likewise, when the ECD inducible MEF cell lines were treated with Thapsigargin for 
various time points (3, 6, 12 or 24h), ECD overexpressing MEFs exhibited lower levels of 
p-PERK compared to those in control MEFs (Figure 2.13A, compare lanes 1-5 with lanes 
6-10).  A corresponding reduction in the levels of ATF4, a downstream target of PERK 
signaling, was seen in ECD overexpressing MEFs compared to their control MEFs (Figure 
2.13A, compare lanes 3-5 with lanes 8-10); s-XBP1 and ATF6 also were slightly reduced 
in ECD over-expressing MEFs (Figure 2.13A, compare lanes 1-5 with lanes 6-10). Similar 
to Thapsigargin, induction of ER stress with Tunicamycin, which induces ER stress by 
inhibiting glycosylation of proteins in the ER, was also associated with lower levels of p-
PERK and p-eIF2α in ECD overexpressing MEFs as compared to control MEFs (Figure 
2.13B, compare lanes 2-5 with lanes 7-10).  Taken together, these results strongly support 
a conclusion that ECD negatively regulates PERK signaling. 
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Figure 2.13: Decreased UPR signaling in ECD inducible MEFs correlated with in 
chaperones induction upon Thapsigargin treatment. (A-B): ECD inducible MEFs 
[(Tet(O)-Flag- hECD-IRESeGFP;rtTA)]  or control MEFs [(Tet(O)-Flag- hECD-
IRESeGFP)] were treated with Dox for 48 h followed by treatment with Thapsigargin. Cell 
lysates were prepared at indicated time points and equal amount of proteins was resolved 
on SDS-PAGE gel followed by western blot with indicated antibodies 
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2.4.7 ECD overexpression protects cells from ER stress-induced cell death 
ER stress response is initially aimed at the survival of cells (76); however severe ER stress 
shifts the response from a pro-survival to a pro-apoptotic response (36,44) through PERK-
mediated induction of CHOP expression, a transcription  factor that enhances the 
expression of pro-apoptotic pathway genes (37-41,43,44,77). Several studies found that 
inhibition of the PERK pathway protected cells against stress-induced cell death (78-81). 
Given our observations that ECD functions as a modulator of PERK signaling, we assessed 
if the level of ECD determines a differential survival vs. apoptotic cell fate upon ER stress 
induction. For that purpose, we treated control MEFs or Dox-inducible ECD 
overexpressing MEFs with Thapsigargin and then assessed the level of apoptosis induction 
by examining caspase 3 cleavage (82). As anticipated, a Thapsigargin dose-dependent 
increase in cleaved caspase 3 levels was observed in control MEFs, whereas the levels of 
cleaved caspase 3 were markedly lower in ECD-overexpressing MEFs (Figure 2.14). 
Moreover, given the role of stress-activated protein kinases SAPK/JNK in mediating ER 
stress-induced cell death, as a downstream target of IRE1α (44,83,84), we further assessed 
the levels of phospho-SAPK/JNK. Notably, while the p-SAPK/JNK level increased in 
response to Thapsigargin in control MEFs, no changes were observed in ECD-
overexpressing MEFs (Figure 2.14, compare lane 1-3 to 4-6). 
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Figure 2.14: Decreased cleaved caspase 3 and p-SAPK/JNK levels in ECD 
overexpressing MEF upon Thapsigargin. ECD was induced as described in (Fig. 3 and 
4) followed by Thapsigargin treatment for 24 h. Equal amount of proteins was resolved on 
SDS-PAGE gel followed by western blot with indicated antibodies 
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To further assess the pro-survival effects of ECD against apoptotic cell fate upon ER stress 
induction, we assessed the abilities of control vs. ECD-overexpressing MEFs to form 
colonies after their exposure to ER stress. For this purpose, equal numbers of control or 
ECD overexpressing MEFs were treated with Thapsigargin for 24h, and the cells were 
maintained in Thapsigargin-free medium for 10 days followed by crystal violet staining 
and counting of surviving colonies. Notably, more colonies were observed in ECD 
overexpressing MEFs as compared to control MEFs (Figure 2.15), further supporting the 
conclusion that ECD provides survival advantage upon ER stress. 
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Figure 2.15: Increased colony formation in ECD over-expressing MEFs upon 
Thapsigargin. After ECD induction, control and ECD inducible MEFs were trypsinized 
and equal number of cells (1,000) were plated in triplicates. 8 h later, the cells were 
treated with Thapsigargin for 24h. 10 days later, surviving colonies were assessed by 
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Crystal blue staining (0.5% in 25% Methanol). The color retained after the wash was 
dissolved in 10% Acetic acid and the absorbance was read at 590 nm. The graph below 
represents the relative absorbance; Mean +/- SD and p-values from 4 independent 
experiments are indicated ** p≤0.002. 
----------------------------------  
 
 
2.4.8 ECD co-localizes and associates with PERK, ATF6, IRE1α and GRP78 
Given the roles of ECD in modulating ER stress as presented above, we sought to define 
the possible mechanism (s). Previously, ECD has been reported to localize, predominantly, 
in the cytoplasm with a fast nuclear export, allowing it to shuttle through the nucleus (85). 
Given the roles of ECD in attenuating ER stress signaling, particularly PERK, we first 
asked whether ECD could also be localizing to the ER or co-localizes with the upstream 
mediators of the ER stress signaling, especially as previous works from the lab showed a 
peri-nuclear localization for ECD, which is the classic definition of an ER localization. 
Therefore, we performed a proximity ligation assay (PLA) to assess the localization of 
ECD relative to PERK and GRP78. Known ECD interaction with PIH1D1 component of 
the R2TP served as the positive control (55,59). Indeed, ECD and PIH1D1 formed distinct 
foci detectable by PLA (Figure 2.15B, red dots). Significantly, PLA signals were also 
observed for ECD and GRP78 or ECD and PERK (Figure 2.15 C-D). Negative controls 
(IgG) did not show any PLA signal (Figure 2.15 E).  
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Figure 2.15: ECD co-localizes with PERK and GRP78. MCF-10A cells were fixed with 
3% PFA and stained with indicated antibodies (all antibodies were generated in rabbit 
except anti-ECD mouse antibody) followed by species-specific secondary antibodies 
linked to complementary DNA probes to allow fluorescent probe-based detection of the 
PCR amplification product as distinct foci. Incubation with Proximity Ligation Assay plus 
and minus probes, followed by ligation and amplification, was carried out according to the 
manufacturer protocol. Red dots indicate interaction. ECD and PIH1D1 served as the 
positive control. 
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The localization of ECD close to the ER stress signaling mediators prompted us to assess 
their association. For that purpose, we carried out immunoprecipitation (IP) of ECD from 
lysates from MCF-10A cell followed by western blotting for PERK, GRP78, IRE1α, and 
ATF6 antibodies to assess their association. IP of ECD co-immunoprecipitated PIH1D1 
(Figure 2.16) as expected based on known interaction of ECD with PIH1D1 (55,59). 
Importantly, PERK, GRP78, IRE1α and ATF6 also co-immunoprecipitated with ECD 
(Figure 2.16).  
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Figure 2.16: ECD associates with PERK, GRP78, IRE1α and ATF6. Lysates from 
MCF-10A cells were subjected to IP with anti-ECD antibody overnight followed by 
Western blotting with indicated antibodies. ECD and PIH1D1 served as the positive 
controls. 
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To further asses these results, we carried out a GST pull down experiment by incubating 
bacterially purified GST-fused full length ECD, C-terminal and N-terminal deletion 
mutants ECD with cell lysate containing overexpressed GRP78, IRE1α, PERK and ATF6 
followed by western blot with the respective antibodies; this GST pull down experiment 
will help define the domain(s) on ECD required for their association. Known interaction of 
full length GST-ECD with RUVBL1/Pontin was used as a positive control (55). As 
expected, full length GST-ECD pulled down RUVBL1/Pontin (Figure 2.17). Significantly, 
full length ECD interacts with GRP78, IRE1α and ATF6. N-terminal and C-terminal 
deletions of ECD abrogated interaction with GRP78 and ATF6 (Figure 2.17) while only 
the C-terminal deletion of ECD abrogated interaction with IRE1α (Figure 2.17), suggesting 
that both the N and C termini are required for interaction with GRP78 and ATF6 but only 
the C-terminus is required for interaction with IRE1α. GST-ECD did not pull down PERK.  
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Figure 2.17: Defining the domain (s) on ECD required for interaction. 3µg of 
bacterially purified GST fused ECD full length (FL) and its mutants were incubated with 
lysates from 293T cells overexpressing GRP78, IRE1α and ATF6 for 3h at 4°. The GST 
beads were washed and resolved on SDS-PAGE gel followed by western blot with 
indicated antibodies. Pontin and  ECD interaction served as a positive control. Below the 
blot is the ponceau. 
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2.4.9 ECD associates with GRP78 and PERK upon ER stress induction 
We further examined the ER stress-related roles of ECD by assessing its association with 
PERK and GRP78 upon ER stress induction. For that purpose, we carried out 
immunoprecipitation (IP) of ECD from lysates from the MCF-10A cell, treated or left 
untreated with Thapsigargin, followed by western blotting for PERK and GRP78 
antibodies to assess their association. IP of ECD co-immunoprecipitated PIH1D1 (Figure 
2.18A), as expected based on known interaction of ECD with PIH1D1 (55,59). 
Importantly, PERK and GRP78 also co-immunoprecipitated with ECD (Figure 2.18A). A 
reverse IP of GRP78 also co-immunoprecipitated ECD, with PERK used as a positive 
control (Figure 2.18B). Taken together, these results suggest that ECD associates with 
PERK and GRP78. 
 
 
 
 
 
 
 
 
92 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ECD 
Tg:                 -                 +                                              -                   + 
Input IP: ECD IgG 
PERK 
GRP78 
PIH1D1 
A 
93 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.18: ECD association with PERK and GRP78 upon ER stress induction. 
Lysates from MCF-10A cells, treated or left untreated with Thapsigargin, were subjected 
to IP with anti-ECD antibody (A) or anti-GRP78 (B) followed by Western blotting with 
indicated antibodies. ECD and PIH1D1(A) or GRP78 and PERK (B) served as positive 
controls. 
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 2.4.10 ECD does not modulate enzymatic activity of PERK in vitro 
Given that ECD associates with PERK and modulates its signaling, we hypothesized that 
ECD could be affecting PERK signaling either directly or indirectly. To test the direct 
hypothesis, we assessed the possibility that ECD affects PERK enzymatic activity. We 
performed an in vitro kinase assay of PERK with its substrate eIF2α in the presence of an 
increasing concentration of pure ECD protein. This experiment showed that eIF2α 
phosphorylation did not change in the presence of an increasing concentration of ECD 
(Figure 2.19), suggesting that ECD does not directly modulate PERK enzymatic activity.  
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Figure 2.19: ECD does not modulate enzymatic activity of PERK toward eIF2α. In 
vitro kinase assay of recombinant human GST fused PERK with its substrate eIF2α in the 
presence of increasing concentration of pure ECD protein. Proteins were separated by 
SDS-PAGE, transferred to PVDF membrane, and phosphate labeling was detected by 
autoradiography. 
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2.4.11 ECD positively regulates levels of chaperones, predominantly, GRP78 protein 
The results above that ECD does not modulate the enzymatic activity of PERK ruled out 
the possibility of a direct effect on PERK signaling. Therefore, we examined the next 
possibility of an indirect mechanism whereby ECD acts through another protein to 
modulate PERK. GRP78 is a repressor of the three arms of the ER stress signaling, 
including PERK, of which it is known to bind to the luminal domain to repress its 
activation in unstressed cells (13,14). The dissociation of GRP78 from PERK upon ER 
stress is key to activation of PERK signaling, but it is also a reversible process, as GRP78 
is also known to bind back to PERK to inhibit its signaling when the stress is relieved. 
Accordingly, we asked whether ECD could be cooperating with GRP78 to modulate 
PERK signaling especially since ECD and GRP78 associate (Figure 2.16-2.18). To 
explore that possibility, we first examined the changes in the levels of GRP78 in the 
presence and absence of ECD upon ER stress induction. We first exposed the wild-type 
MEFs or MEFs with ECD deletion induced by adeno-Cre to Thapsigargin, and then 
assessed the levels of GRP78 protein, at various time points, by western blotting. The 
levels of GRP78, over time, were reduced in ECD-null MEFs compared to GRP78 levels 
in control MEFs (Figure 2.20A, compare lanes 3-5 with 8-10). Likewise, using 
physiological stress, a knock down of ECD in Panc-1 cells led to a decrease in GRP78 
levels upon glucose starvation (Figure 2.20B, compare lanes 1-5 with lanes 6-10).  
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Figure 2.20: ECD deletion or knock down led to a reduced induced levels of GRP78. 
(A): Ecd fl/fl MEFs were treated with adenovirus as previously described and then the 
cells were treated with Thapsigargin (50 nM); (B): ECD was knocked down by siRNA 
(20 nM) in Panc-1 cells followed by exposure to glucose-free media. Cell lysates were 
collected at indicated time points followed by western blot with indicated antibodies. 
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To further examine these effects, we used a reciprocal approach by overexpressing ECD 
and assessing GRP78 protein levels upon ER stress induction. In the presence of 
overexpressed ECD, upon induction of ER stress by Thapsigargin treatment, the levels of 
GRP78 were robustly elevated (Figure 2.21A). GRP94 and PDI, two other chaperones 
with ER stress-related functions, were also increased although not as robustly as GRP78 
(Figure 2.21A). Similar results were obtained with Tunicamycin treatment, another ER 
stress inducing chemical (Figure 2.21B). 
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Figure 2.21: ECD overexpression led to a robust increase in chaperone levels, 
predominantly, GRP78. ECD inducible MEFs [(Tet(O)-Flag- hECD-IRESeGFP;rtTA)]  
or control MEFs [(Tet(O)-Flag- hECD-IRESeGFP)] were treated with Dox for 48 h 
followed by treatment with Thapsigargin (50 nM, A) or Tunicamycin (50 ng/ml, B). Cell 
lysates were prepared at indicated time points and equal amount of proteins was resolved 
on SDS-PAGE gel followed by western blot with indicated antibodies. 
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2.4.12 ECD does not affect GRP78 transcription or mRNA stability 
Based on the distinct effect of ECD depletion or overexpression on GRP78 protein levels, 
we next examined GRP78 mRNA induction in the presence or absence of ECD. We 
carried out qPCR analyses of mRNA isolated from WT or ECD-null MEFs treated with 
Thapsigargin. As expected, GRP78 mRNA levels increased in WT MEFs upon 
Thapsigargin treatment (Figure 2.22A); however, the levels of GRP78 mRNA induction 
in ECD-null MEFs was comparable to that in control MEFs (Figure 2.22A). Similarly, 
GRP78 mRNA levels in control vs. ECD overexpressing MEFs treated with Thapsigargin 
were comparable (Figure 2.22B). Likewise, we examined the post-transcriptional effect 
of ECD on GRP78 mRNA stability by treating cells with Actinomycin D, to inhibit 
mRNA synthesis, and collected mRNA at various time points followed by qPCR with 
primers against GRP78 mRNA. The rate of decrease of GRP78 mRNA over time is 
comparable between ECD depleted or overexpressed cells and their respective controls 
(Figure 2.23A-B), suggesting that ECD does not affect GRP78 mRNA stability. Taken 
together, these results suggest that ECD does not affect GRP78 mRNA transcription or 
post-transcriptionally. 
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Figure 2.22: Effect of ECD on GRP78 mRNA induction. Following ECD deletion by 
Adeno-CRE infection (A) or ECD overexpression (B) and Thapsigargin treatment, the 
levels of GRP78 mRNA were assessed in WT (control) vs. ECD-/- (Cre-adenovirus 
treated) or control vs. ECD overexpressing MEFs using qRT-PCR. 
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Figure 2.23: Effect of ECD on GRP78 mRNA stability. Following ECD deletion by 
Adeno-CRE infection (A) or ECD overexpression (B) and Thapsigargin treatment, the 
cells were treated with Actinomycin D and mRNA was collected at indicated time points. 
The levels of GRP78 mRNA were assessed in WT (control) vs. ECD-/- (Cre-adenovirus 
treated) or control vs. ECD overexpressing MEFs using qRT-PCR. 
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2.4.13 ECD enhances GRP78 protein stability and this effect is required for ECD to 
attenuate ER stress signaling 
The results above showing that ECD does not regulate GRP78 protein at mRNA level 
raised a strong possibility that ECD might instead regulate GRP78 at protein level 
especially since the two protein associated. To determine whether GRP78 may be less 
stable in ECD null cells or more stable in ECD overexpressing cells, we first knocked 
down ECD in Panc-1 cells, which have high levels of GRP78, followed by inhibition of 
protein synthesis by cycloheximide treatment over various time points and GRP78 
protein levels were analyzed by western blot. Significantly, the time dependent decrease 
in GRP78 protein levels following cycloheximide treatment was faster in ECD-knocked 
down cells compared to their control cells (Figure 2.24A).  Next, to examine the 
possibility that ECD overexpression is associated with increased GRP78 protein stability, 
control or ECD overexpressing cells were treated with Thapsigargin to induce GRP78 
protein, followed by cycloheximide (CHX) treatment over various time points. Notably, 
the time-dependent decrease in GRP78 levels was slower in ECD overexpressing MEFs 
as compared to control MEFs (Figure 2.24B). Finally, to determine whether the increase 
in GRP78 protein stability upon ECD overexpression was required for the attenuation of 
PERK activation seen upon ER stress induction, we depleted GRP78 using siRNA in 
both control and ECD overexpressing MEFs followed by Thapsigargin treatment. 
Notably, even in the presence of overexpressed ECD, the attenuating effect of ECD 
overexpression on PERK phosphorylation upon Thapsigargin treatment was abrogated by 
GRP78 knockdown (Figure 2.24C; compare lane 5-6 with 7-8). Furthermore, this knock 
down of GRP78 reduced the survival effect of ECD overexpression by reducing the 
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colonies’ ability to form the ECD overexpressing cells (Figure 2.24D, compare lane 2 
and 4). Taken together, these results support the conclusion that ECD positively regulates 
GRP78 protein level upon ER stress induction to attenuate PERK activation and provide 
survival advantage. 
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Figure 2.24: ECD mediated GRP78 protein stability is required for ECD ER stress 
function. (A): ECD was knocked down in Panc-1 cells followed by cycloheximide 
treatment (25 uM). Cell lysates were prepared at indicated time points followed by 
western blot with indicated antibodies. (B): ECD inducible MEFs and their control MEFs 
were treated with Dox, as described previously, followed by treatment with Thapsigargin 
and then Cycloheximide treatment (25 uM) for indicated time points. Cell lysates were 
prepared followed by western blotting with indicated antibodies. (C): ECD 
overexpressing and their control MEFs were treated with GRP78 SiRNA (30 nM) or 
control siRNA (scrambled). 24 h later, the cells were treated with Dox for 48 h to induce 
ECD overexpression followed by Thapsigargin treatment (50 nM). Equal amount of 
proteins was resolved on SDS-PAGE gel followed by western blotting with indicated 
antibodies. (D): After ECD induction, control and ECD inducible MEFs were trypsinized 
and equal number of cells (1,000) were plated in triplicates. 8 h later, the cells were 
treated with Thapsigargin for 24h. 10 days later, surviving colonies were assessed by 
crystal blue staining (0.5% in 25% Methanol). The color retained after the wash was 
dissolved in 10% Acetic acid and the absorbance was read at 590 nm. The graph below 
represents the relative absorbance; Mean +/- SD and p-values from 3 independent 
experiments are indicated ** p≤0.002 
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2.5 DISCUSSION 
 
The ER-localized stress response pathway referred to as the UPR is a well-conserved 
response to a number of cellular stresses such as unfolding of proteins in the ER. The UPR 
elicits a spectrum of downstream responses whose outcomes range from restoration of 
homeostasis to cellular apoptosis if the stress is extreme and prolonged (36,44). The UPR 
thus represents a double-edged sword and must be intricately regulated to prevent 
inappropriate cellular outcomes. Mechanisms that help modulate the magnitude and type 
of the UPR in response to physiological or pathological stress stimuli are not fully 
understood.  In this study, we provide evidence that ECD protein is a repressor of stress 
response. 
Several lines of circumstantial evidence discussed in the Introduction section 
suggested a potential involvement of ECD in UPR but direct support for such a role has 
been lacking. To explore a connection of ECD to stress response pathways, we first 
assessed the effects of multiple stress stimuli on ECD protein levels. Induction of stress 
both chemically (Thapsigargin, Tunicamycin, BFA, DTT, sorbitol, and H2O2) and 
physiologically (glucose starvation and NOX4 expression) in multiple cell lines led to 
downregulation of ECD protein levels (Figure 2.1-2.3). The concomitant increase in ECD 
mRNA levels (Figure 2.4) suggests that the protein was transcriptionally induced. By using 
AFT6 KO, IRE1α and PERK kinase knockout (KO), we found that PERK is the upstream 
mediator of the decrease in ECD protein levels and that in PERK KO MEFs, ECD protein 
and mRNA levels did not change upon ER stress induction (Figure 2.5-2.6). Since ECD is 
not a substrate for PERK phosphorylation (Figure 2.7) but ECD protein levels did not 
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change when eIF2α phosphorylation, the downstream effect of PERK activation, was 
disrupted (Figure 2.8), the results strongly suggest that ECD protein levels are regulated 
via the PERK-eIF2α axis upon ER stress induction. Since that axis controls translation 
upon stress induction, then the results further suggest that ECD protein undergoes a PERK-
eIF2α-dependent translation block upon ER stress. The decrease in ECD protein levels in 
other forms of stress, including oxido-reductive and osmotic stresses, further argues that 
induction of stress in general leads to an eIF2α-dependent decrease in ECD protein levels. 
In fact, all forms of cellular stress, including viral infection and nutrient limitation in 
addition to those mentioned above, converge to a common node, eIF2α. Moreover, they 
are interconnected. For instance, viral infection induces ER stress (86) due to the increase 
viral protein synthesis. Oxidative stress and nutrient limitation also induce ER stress (87-
89).  
With regard to ER stress, these findings linked ECD to the PERK-eIF2α pathway. 
A functional connection of ECD to the PERK arm of the UPR is supported by the distinct 
modulation of the PERK-mediated responses elicited by perturbations of the cellular levels 
of ECD. Depletion of ECD sensitized cells to PERK signaling in response to Thapsigargin 
treatment, with increase in p-PERK and p-eIF2α levels, as well as an increase in the 
downstream effector of PERK, the transcription factor CHOP, altogether led to increased 
caspase 3 cleavage and reduced survival of these ECD depleted MEFs (Figure 2.10). 
Similarly, physiological stress by glucose deprivation in a human pancreatic carcinoma cell 
line (Panc-1) upon ECD knock down resulted in increased ER stress with enhanced p-
eIF2α, spliced XBP-1 and cell death (Figure 2.11). Reciprocally, upregulation of ECD 
reduced PERK signaling upon induction of ER stress (Figure 2.12). As activation of the 
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PERK pathway promotes cell death in response to ER stress, primarily through CHOP-
dependent expression of pro-apoptotic genes (37-45) and abrogation of PERK signaling 
protects cells against stress-induced cell death (78-80), our results supported the likelihood 
that ECD functions to modulate PERK pathway activity and promote cell survival during 
ER stress. Indeed, assessment of cellular survival in response to ER stress showed that 
reduction in ECD levels impaired cell survival to ER stress (Figure 2.10) while 
overexpression of ECD promoted cell survival (Figure 2.14).  
Collectively, these results support the conclusion that ECD and PERK are linked 
through a negative feedback mechanism whereby ECD exerts an inhibitory effect on PERK 
pathway signaling and activated PERK in turn reduces ECD protein levels via eIF2α-
dependent translational block. Consistent with a reciprocal negative feedback relation 
between ECD and PERK, activated PERK negatively regulates cell growth (46-48); 
conversely,  ECD positively regulates cell growth (54) and is overexpressed in human 
breast and pancreatic cancer specimens, correlating with poor prognostic markers and 
shorter survival (69,90).  While the physiological benefit of an increased ECD mRNA upon 
ER stress is not yet understood, a speculation is that this effect may reflect a feedback 
response to the decrease in ECD protein levels whereby cells may try to compensate for 
the loss of ECD but ECD translation is blocked. Although ECD has been reported to play 
roles in pre-mRNA splicing in drosophila (91), it is unlikely that ECD alters its own mRNA 
splicing upon ER stress because ECD protein levels decrease upon ER stress. 
 Modulation of ECD levels using knockdown or overexpression demonstrated that 
ECD is a positive regulator of GRP78 levels (Figure 2.20 and 2.21). While slight increases 
in GRP94 and PDI were observed, the effect on GRP78 was more dramatic. However, this 
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effect may be post-translational since ECD did not have a transcriptional or post-
transcriptional effect on GRP87 mRNA. The slight increase in GRP94 and PDI, both of 
which have ER stress-related functions, further suggests that ECD may affect chaperones’ 
levels, in general, when overexpressed upon ER stress induction.  
As increased expression of GRP78 and other chaperones is known to promote the 
clearing of ER stress-causing unfolded protein load and reduce the activation of UPR 
sensors (13-15,20), this increase in chaperones levels in the presence of ECD upon ER 
stress induction argue that ECD may be repressing stress by elevating chaperone levels. 
Indeed, a knock down of GRP78 abrogated the attenuating effect of ECD on PERK 
signaling even in the presence of overexpressed ECD (Figure 2.24C). Notably, GRP78 is 
required for cell survival not only in response to ER stress (23,92-94) but also in other 
stressful and hostile conditions such as glucose deficiency encountered in tumor 
microenvironments (95-100). Given that the PERK arm of the UPR is also activated in 
cancer (77,101,102) and both ECD and GRP78 are overexpressed in cancer (69,90,95-
100), we suggest that ECD overexpression may play a similar role to mitigate the negative 
consequences of elevated PERK signaling found in cancer. Given the mechanistic link 
between ECD and GRP78 in inhibiting the PERK pathway to promote cell survival, it will 
be of great interest to explore if GRP78 and ECD are co-overexpressed in tumors that use 
the UPR to promote tumor cell survival and hence may be suitable targets for UPR-directed 
therapeutic agents. 
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ECD protein has been known for many years as an important cell growth regulatory 
protein. The overexpression of ECD in cancer, including breast, prostate and pancreatic 
cancers, strongly suggests oncogenic roles for ECD. In this study, we presented evidence 
for an involvement of ECD in ER stress in cancer. Normal or cancer cell lines with low 
levels of ECD exhibited increased ER stress and cell death upon ER stress induction. 
Conversely, ECD overexpressing cells exhibited a decreased ER stress and cell death upon 
ER stress. Together, these distinct effects of ECD knock down or overexpression on cells 
argue that ECD may be functioning as a buffering protein against stress in cells and as a 
regulator of sensitivity of cells to ER stress. The increase in ECD mRNA upon ER stress 
indicates a transcriptional induction of ECD and further suggests an ER stress-related role. 
The functional connection of ECD to the PERK-eIF2α arm of the ER stress signaling 
further argues in favor of the pro-survival roles for ECD in stress conditions, since that axis 
mediates cell death during ER stress signaling via CHOP induction (1-8). ECD inhibits 
PERK-eIF2α signaling while PERK-eIF2α inhibits ECD protein translation, thus 
establishing a negative feedback loop between ECD and the PERK arm of the ER stress 
signaling.  
Mechanistically, ECD may be exerting its effects by multiple ways. Particularly, 
the ECD-GRP78 axis is a novel pathway for regulating ER stress. ECD enhances the level 
of GRP78, a key chaperone and inhibitor of PERK signaling. As increased expression of 
GRP78 and other chaperones is known to promote the clearing of ER stress-causing 
unfolded protein load and reduce the activation of UPR sensors (9-12), this increase in 
chaperones’ levels in the presence of ECD upon ER stress induction argues that ECD may 
be attenuating stress by elevating chaperone levels and enhancing the folding capacity in 
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the stressed ER. Indeed, a disruption of the chaperone-enhancing effect of ECD abrogated 
the attenuating effect of ECD on PERK signaling even in the presence of overexpressed 
ECD. Notably, GRP78 is required for cell survival not only in response to ER stress (13-
16) but also in other stressful and hostile conditions such as glucose deficiency encountered 
in tumor microenvironments (17-22). Given that the PERK arm of the UPR is also activated 
in cancer (8,23,24) and both ECD and GRP78 are overexpressed in cancer (17-22,25,26), 
we suggest that ECD overexpression may play a similar role to mitigate the negative 
consequences of elevated PERK signaling found in cancer. Given the mechanistic link 
between ECD and GRP78 in inhibiting the PERK pathway to promote cell survival, it 
would be of great interest to explore if GRP78 and ECD are co-overexpressed in tumors 
that use the UPR to promote tumor cell survival and hence may be suitable targets for 
therapeutic agents directed against ER stress in cancer.  
 
 
Conclusion: 
 
• Stress induction by multiple stimuli, Thapsigargin, Tunicamycin, glucose 
starvation, H2O2, NOX4 overexpression, DTT, and sorbitol, led to a reduced ECD 
protein in multiple cell lines (MCF7, MDA-468, MCF10A, Panc-1, 76NTERT, 
MDA231-NOX4).  
• ECD mRNA increased upon Thapsigargin treatment. 
• In PERK KO MREFs, the levels of ECD protein did not change upon ER stress 
induction as compared to WT PERK.  
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• In PERK KO MEFs, ECD mRNA levels failed to increase as compared to WT 
PERK. 
• PERK does not phosphorylate ECD. 
• The decrease in ECD protein levels is via the PERK-eIF2α axis of the ER stress 
signaling. 
• Loss of ECD in cells increased the levels of p-PERK, p-eIF2α, and these effects 
were enhanced upon ER stress induction by Thapsigargin treatment or glucose 
deprivation along with an increased in CHOP mRNA, and cleaved caspase 3.  
• Loss of ECD slightly increased the levels of spliced XBP-1, the downstream target 
of IRE1α but cleaved ATF6 did not significantly change.  
• Loos of ECD correlated with a decrease in the colony formation of ECD-null cells 
upon ER stress induction.  
• Overexpression of ECD led to a marked decrease in p-PERK and its downstream 
targets, p-eIF2α, ATF4 and CHOP mRNA levels upon ER stress induction 
• Overexpression of ECD upon ER stress induction slightly increased the levels of 
spliced XBP1 but ATF6 did not change significantly.  
• Overexpression of ECD upon ER stress induction correlated with a decrease in 
caspase 3 cleavage and an increase in the colony formation of ECD overexpressing 
cells  
• ECD localized and associated with PERK, ATF6, IRE1α and GRP78.  
•  ECD did not modulate enzymatic activity of PERK toward eIF2α.  
• Depletion of ECD upon ER stress induction was associated with decreased GRP78 
protein levels. 
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• Overexpression of ECD upon ER stress induction increased the levels of GRP78 
protein. 
• GRP78 mRNA was not affected by deletion or overexpression of ECD upon ER 
stress induction. 
• Knock down of ECD followed by cycloheximide treatment was associated with a 
faster decrease in GRP78 protein level as compared to control cells with intact 
cellular ECD levels. 
• ECD overexpression plus cycloheximide treatment correlated with a slower 
decrease in GRP78 protein levels. 
• A knock down of GRP78 abrogated the attenuating effect of ECD on PERK, even 
in the presence of overexpressed ECD. This effect further correlated with a decrease 
in the colony formation of ECD overexpressing cells.  
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• Characterize ER stress elements (ERSE) in ECD gene promoter 
             The increase in ECD mRNA upon ER stress induction suggests existence of        
              ERSE in ECD gene promoter. A follow-up study to characterize these ERSE  
              would be interesting. 
 
• Assess potential roles of ECD in autophagy through GRP78 
           In addition to further examining the ECD-GRP78 connection in tumor context, it   
           would also be interesting to assess whether ECD pro-survival effect upon ER stress  
           is via GRP78-mediated autophagy.  The rationale is that ECD enhanced GRP78   
           while GRP78 has been implicated in autophagy. Although a clear mechanism was  
           not presented, it was reported in numerous studies that GRP78 was required for  
           autophagy induction and that inhibition of GRP78 inhibited autophagy induction      
           (1-3).  
   
• Assess potential ECD-R2TP connection in regulating ER stress 
            The R2TPcomplex, composed of RUVBL1, RUVBL2, PIH1D1 and RPAP3 is a  
             multi-protein complex which regulates the assembly and stability of many  
             complexes (4). A study identified a role for RUVBL2 in the regulation of ATF2 in  
             response to stress through direct interaction with ATF2 (5). ECD is a component  
             of the R2TP complex (6,7). ECD interacts with the RUVBL1 component of the  
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             R2TP complex, an interaction required for ECD roles in cell growth (33). It is  
             reported that knock of RUVBL1 affected cellular level of GRP78 an induced ER  
             stress (8). Therefore, it would be curious to examine the potential ECD-R2TP  
             connection in ER stress regulation, especially as ECD overexpression correlated   
             with enhanced of both GRP78 and RUVBL1 upon ER stress induction (Figure 4.1  
             below) . 
 
 
 
 
 
 
 
 
Figure 4.1: ECD overexpression correlates with enhancement with RUVBL1 and 
GRP78. ECD overexpressing and their control MEFs were treated with Tunicamycin and 
protein lysate was prepared at indicated time points followed by western blot with indicated 
antibodies. 
ECD 
Tun:         -       3h     6h    12h    24h     -       3h      6h    12h   24h 
Tet(O)-Flag- hECD 
-IRES eGFP; rtTA 
Tet(O)-Flag- hECD 
-IRES eGFP 
GRP78 
RUVBL1 
β-actin 
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• Assess the requirement of ECD in chaperone (GRP78, GRP94)-mediated ER 
calcium regulation.  The ER is well known as a site for calcium storage in cells. 
ECD regulates the levels of the critical chaperone proteins (GRP78 and GRP94) 
that mediate that function of the ER (9,10). 
  
• Assess the roles of ECD in protein translation through GRP78. GRP78 is 
known to be involved in protein translation not only by binding nascent protein in 
the ER but importantly by forming the translocation channel in complex with Sec61 
(11,12). 
 
• Explore in vivo studies of the ECD-GRP78 axis in regulating oncogenesis-
induced ER stress in mouse models. Works in the lab indicated potential 
oncogenic roles of ECD, as its overexpression induced tumors. Tumor initiation 
and progression are complex processes characterized by ER stress as a result of the 
increased bioenergetics demands in the tumor. Overcoming this early ER stress is 
paramount for tumor progression. It would be interesting to assess whether the 
ECD-mediated upregulation in the levels of GRP78 is required for tumor initiation 
and progression. 
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 22 
ABSTRACT 23 
The mammalian Ecdysoneless (ECD) is a highly-conserved ortholog of the Drosophila Ecd gene 24 
product whose mutations impair the synthesis of Ecdysone and produce cell-autonomous 25 
survival defects but mechanisms by which ECD functions are largely unknown. Here, we present 26 
evidence that ECD regulates endoplasmic reticulum (ER) stress response. ER stress induction led 27 
to a reduced ECD protein but this effect was not seen in PERK KO or phospho-deficient eIF2α 28 
MEFs; moreover, ECD mRNA levels were increased, suggesting impaired ECD translation as 29 
the mechanism for reduced protein levels. ECD co-localizes and co-immunoprecipitates with 30 
PERK and GRP78.  ECD depletion increased the levels of p-PERK, p-eIF2α, and these effects 31 
were enhanced upon ER stress induction. Reciprocally, overexpression of ECD led to a marked 32 
decrease in p-PERK, p-eIF2α and ATF4 levels, but a robust increase in GRP78 protein levels.  33 
However, GRP78 mRNA levels were unchanged, suggesting a post-transcriptional event. 34 
Knockdown of GRP78 reversed the attenuating effect of ECD over-expression on PERK 35 
signaling. Significantly, overexpression of ECD provided a survival advantage to cells upon ER 36 
stress induction. Taken together, we demonstrate that ECD promotes survival upon ER stress by 37 
increasing GRP78 protein levels to enhance the adaptive folding protein in the ER to attenuate 38 
PERK signaling. 39 
40 
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INTRODUCTION 41 
 The endoplasmic reticulum (ER) is a central subcellular organelle with essential roles in the 42 
synthesis, folding and maturation of secreted and membrane proteins, biogenesis of cholesterol, 43 
calcium homeostasis and regulation of survival and apoptosis pathways (1-10). Aberrations in 44 
these ER functions are sensed by well-conserved ER transmembrane sensors, Inositol-Requiring 45 
Enzyme 1 alpha (IRE1α), PKR-like ER kinase (PERK) and Activating Transcription Factor 6 46 
(ATF6), that activate homeostatic signaling pathways collectively referred to as the unfolded 47 
protein response (UPR) (11,12). These ER stress sensors exhibit a dynamic and reversible 48 
interaction with the ER chaperone GRP78 (13). In un-stressed cells, GRP78 is bound to luminal 49 
domains of UPR sensors, which maintains them in an inactive state (14). During ER stress, the 50 
increased load of unfolded proteins competes for GRP78 binding, leading to activation of UPR 51 
sensors (15) which, through intermediate signaling, evoke overlapping as well as pathway-52 
specific responses to restore ER homeostasis and promote cell survival or alternatively eliminate 53 
stressed cells through apoptosis if homeostasis cannot be restored. 54 
The PERK pathway has emerged as a key pathway in cellular UPR response as well as 55 
homeostasis under unstressed conditions and in disease states (16-21). Release of GRP78 from 56 
PERK leads to its dimerization, auto-phosphorylation and activation (15,22,23). A major PERK 57 
substrate is the eukaryotic translation initiation factor 2 alpha (eIF2α) whose phosphorylation by 58 
PERK inactivates it leading to a block in general cap-dependent protein translation and 59 
consequent decrease in the protein load entering the ER (24); concurrently, PERK signaling 60 
selectively enhances the cap-independent translation of specific mRNAs, such as Activating 61 
Transcription Factor 4 (ATF4) (24). ATF4 induces the expression of CCAAT/enhancer-binding 62 
protein-homologous protein (CHOP) which promotes apoptosis in response to stress (24-32). 63 
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PERK-induced phosphorylation of eIF2α also inhibits cell cycle progression by reducing the 64 
levels of cyclins and hence cyclin-dependent kinase 2 (CDK2) activity (33-35). Termination of 65 
PERK signaling, together with de-phosphorylation of eIF2α, is required to re-initiate protein 66 
synthesis and resume cell cycle. Thus, PERK-mediated UPR leads to a coordinated program of 67 
cellular protection and mitigation of stress. However, PERK also contributes to an alternate 68 
outcome through CHOP-mediated activation of a cellular death pathway to eliminate severely 69 
damaged cells (24-32). Mechanisms to fine-tune the outcomes of UPR pathways are important to 70 
mitigate the negative consequences of ER stress. This is of particular importance under 71 
conditions where cells experience ER stress as part of their physiological responses, such as 72 
antibody-secreting plasma cells or insulin-secreting pancreatic islet cells (36). We have identified 73 
ECD as a negative regulator of the PERK-mediated UPR. 74 
The Ecd gene was first identified based on genetic mutations in Drosophila that lead to reduced 75 
production of the developmentally-regulated steroid hormone Ecdysone, which is synthesized in 76 
the ER, hence the designation of ecdysoneless for such fly mutants (37). The mammalian Ecd 77 
gene was cloned based on the rescue of growth defects in S. cerevisiae mutant in the growth 78 
control regulatory gene 2 (GCR2), a glycolysis regulatory gene (38). Thus, ECD was thought to 79 
be involved in mammalian glycolysis gene expression and initially named hSGT1 (human 80 
suppressor of gcr2)(38). We identified the same gene in a screen for interacting partners of 81 
human papilloma virus E6 oncoprotein and found it to interact with p53 and transactivate p53-82 
regulated genes  (39,40). 83 
To elucidate the functional role(s) of mammalian ECD, we generated Ecd-null mice and 84 
demonstrated that homozygous deletion of Ecd was early embryonic lethal while ex vivo Cre-85 
mediated deletion of Ecd in Ecdfl/fl mouse embryonic fibroblasts (MEFs) led to proliferative 86 
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block and a significant decrease in cell survival (41,42). ECD was found to be essential for E2F 87 
target gene expression by facilitating the dissociation of the retinoblastoma RB protein  from 88 
E2F and promoting the G1-to-S phase cell cycle progression (41). As a consequence, Ecd-null 89 
MEFs showed a decrease in the levels of cyclins A, B1, E and D1, reduction in CDK2 kinase 90 
activity and were arrested in G1 phase of the cell cycle (41). Interestingly, E2F family proteins 91 
such as the E2F1 have been implicated in UPR-mediated cell death (43). In addition to its 92 
promotion of the G1/S phase, ECD also promotes G2/M phase of the cell cycle and its 93 
knockdown induced not just a G2/M arrest but also apoptosis (44). Induction of UPR not only 94 
induces apoptosis but also halts cell cycle progression in G1 and G2 phases (33-35,45) and these 95 
effects are mediated by PERK (33,34), suggesting a potential connection between ECD and the 96 
PERK arm of the UPR.  97 
More recently, we uncovered another mechanism by which ECD regulates cellular proliferation, 98 
involving its interaction with RUVBL1 and PIH1D1 components of the prefoldin co-chaperone 99 
R2TP (42) which is involved in the assembly or remodeling of a number of protein and protein-100 
RNA complexes to regulate many physiological processes (46-52). Recently, it was reported that 101 
knock down of the RUVBL1 component of the R2TP complex induced cell cycle block and ER 102 
stress (53). Furthermore, ECD has been shown to associate with the stress response protein 103 
Thioredoxin-Interacting Protein (TXNIP) (54) which is known to bind to the ER chaperone PDI 104 
(protein disulfide bond isomerase) to increase its enzymatic activity to relieve ER stress (55). 105 
Lastly, TXNIP was recently shown to be a novel component of the UPR and is regulated by the 106 
PERK pathway (56). Thus, multiple lines of suggestive evidence pointed to a potential role of 107 
ECD in the regulation of ER stress.  In this study, we demonstrate that induction of ER stress, 108 
using both chemical ER stress inducers (Thapsigargin and Tunicamycin) and physiological ER 109 
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stress inducers (glucose starvation), led to a reduced ECD protein, and this effect was not seen in 110 
PERK KO or phospho-deficient eIF2α MEFs. Notably, ECD mRNA levels were increased, 111 
suggesting impaired ECD translation as a mechanism for reduced protein levels. Moreover, ECD 112 
localizes and co-immunoprecipitates with the unfolded protein response mediators PERK and 113 
GRP78. While ECD depletion increased the levels of p-PERK and its downstream targets, p-114 
eIF2α and ATF4, ECD overexpression markedly decreased their levels upon ER stress induction, 115 
whereas induction of GRP78 protein robustly increased, suggesting an enhanced adaptive folding 116 
capacity of the ER. Knockdown of GRP78 reversed the attenuation of PERK signaling seen upon 117 
ECD overexpression. Significantly, ECD over-expression and depletion distinctly affected the 118 
survival outcome of cells upon ER stress. 119 
 120 
MATERIALS AND METHODS 121 
 Reagents and antibodies- Thapsigargin, (Cat# 12758) and Tunicamycin (Cat# 12819) were 122 
from Cell Signaling, dissolved in DMSO and used at indicated concentrations. SiRNA against 123 
GRP78 was from Santa Cruz (Sc-35522) and Cycloheximide was purchased from Sigma (cat# 124 
7698). A monoclonal antibody against ECD, generated in our laboratory, has been described 125 
previously (57). Antibodies against p-PERK (cat# 3179), ATF4 (cat# 11815), p-eIF2α (cat# 126 
9721), eIF2α (cat# 9722), GRP78 (cat# 3177), Caspase 3 (cat# 9662), GRP94 (cat# 2104), s-127 
XBP1 (cat# 12782), RCAS1 (cat# 6960), PDI (cat# 3501) and total PERK (cat# 3192) were from 128 
Cell signaling. ATF6 and SERCA2 antibodies were purchased from Enzo Life (cat# ALX-804-129 
381-C100) and abcam (ab2861), respectively. PERK and GRP78 used for immunofluorescence 130 
and proximity ligation assay (PLA) were from Santa Cruz (cat# sc-9477) and abcam (ab21685), 131 
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respectively. PIH1D1 was from Santa Cruz (18Y9 sc-101000). GRP78 for IP/WB was purchased 132 
from abcam (cat#21685). 133 
 134 
Establishment of MEFs with doxycycline-inducible ECD over-expression from Ecd transgenic 135 
mice-  MEFs were generated from 13.5 days old embryos of mice of the genotype Tet(O)-Flag-136 
hEcd-IRES-eGFP used as control. rtTA was introduced retrovirally to generate Tet(O)-Flag-137 
hEcd-IRES-eGFP; rtTA (the derivation of the transgenic mice will be described separately). 138 
 139 
  Cell lines and culture conditions- Ecd fl/fl MEFs were maintained in DMEM medium 140 
supplemented with 10% fetal bovine serum and treated with adenoviruses coding for GFP 141 
(adeno-GFP, control) or Cre (adeno-Cre) as described previously (41,42). Panc-1 cells have been 142 
previously described (58). For ECD overexpression studies, control MEFs or ECD over-143 
expressing MEFs were cultured with 1μg/ml of Doxycycline (Cat # 231286, BD Biosciences) to 144 
induce expression of the Ecd transgene. MEFs with a non-phosphorylatable eIF2α were obtained 145 
from Dr. Thomas Rutkowski’s lab, Carver College of Medicine, Iowa and has been described 146 
elsewhere (59). PERK knockout (KO) MEFs were from ATCC (CRL-2976). Immortal human 147 
mammary epithelial cell line MCF-10A was cultured in DFCI-1 medium (42). 148 
  149 
Cellular Fractionation and Immunoprecipitation- Subcellular fractionation of MCF-10A cells 150 
into soluble (GAPDH was used as a marker(42,60)) and microsomal fractions (PERK and 151 
SERCA2 were used as a marker) was carried out according to the manufacturer protocol (Sigma 152 
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Aldrich, Cat# ER0100)(61). For immunoprecipitation (I.P), cells were washed in Phosphate 153 
Buffered Saline (PBS) and lysed in CHAPS buffer [(0.3% CHAPS, 20 mM Tris-HCl (pH 7.4), 154 
120 mM NaCl, 10% glycerol, 5 mM EDTA supplemented with protease and phosphatase 155 
inhibitor (Roche, Cat# 04906837001 and 11836145001)]. 156 
 157 
Western blotting- For western blotting, cell lysates were prepared in RIPA buffer (Cat# 89901, 158 
Thermo Scientific) supplemented with protease inhibitors (Roche, Cat# 11836145001). Lysates 159 
were resolved on SDS-PAGE gel, transferred on to nylon membrane (IPVH00010, Millipore), 160 
and subjected to ECL-based Western blotting as described (41,42). 161 
 162 
Immunofluorescence analysis- Immortal MEFs were cultured on coverslips, fixed for 30 min in 163 
3% Paraformaldehyde (PFA) and permeabilized in PBS (containing 0.5 % Triton X-100 and 164 
10% goat serum) for 20 min at room temperature, followed by blocking in PBS (containing 10% 165 
goat serum) for 1 hour at room temperature. The cells were then incubated with primary 166 
antibodies in blocking buffer overnight at 4°C followed by 1-hour incubation with their 167 
corresponding secondary antibodies in blocking buffer at room temperature. Cells were then 168 
washed in PBS (containing 0.1% Tween-20) and then mounted for confocal with the super-169 
resolution structure-illuminated microscopy (SIM). Confocal images were obtained using the 170 
Carl Zeiss LSM 510 microscope and 3D-SIM images were collected with a Zeiss ELYRA PS.1 171 
illumination system (Carl Zeiss).  172 
 173 
 o
n
 June 29, 2017 by UNIV O
F NEBRASKA M
ED CTR
http://m
cb.asm
.org/
D
ow
nloaded from
 
 
 
9 
 
Proximity Ligation Assay (PLA)- PLA was previously described (62). Briefly, MCF-10A cells 174 
were fixed with 3% PFA, stained with the indicated antibodies and incubated with Proximity 175 
Ligation Assay plus and minus probes followed by ligation and amplification reaction according 176 
to the manufacturer’s protocol (DuoLink Sigma). 177 
 178 
Colony Formation Assay- For clonogenic assay, 1,000 cells were plated in triplicate and allowed 179 
to attach to the plate (about 8 h) followed by treatment with Thapsigargin for 24h. 10 days later, 180 
colony formation was assessed as previously described (41,42). 181 
 182 
RNA isolation and real-time quantitative PCR (qRT-PCR)- Total RNA was isolated using the 183 
TRizol reagent (Invitrogen cat# 15596018). 1 µg of RNA was reverse- transcribed using 184 
SuperScript TMII reverse transcriptase (Invitrogen cat# 18064014). The qPCR was performed 185 
with primer sets indicated in the table: 186 
Primers used for the Real-time quantitative PCR 
Genes Forward primer Reverse primer 
mouse CHOP CTGCCTTTCACCTTGGAGAC CGTTTCCTGGGGATGAGATA 
human CHOP  CATTGCCTTTCTCCTTCGGG CCAGAGAAGCAGGGTCAAGA 
mouse GRP78 AGTGGTGGCCACTAATGGAG CAATCCTTGCTTGATGCTGA 
mouse Ecd CCGGTCTGGCACAAACTTCTGCTG AGGGTCGAAGCATCCCTCCATCGA 
human Ecd   ACTTTGAAACACACGAACCTGGCG TGATGCAGGTGTGTGCTAGTTCCT 
 187 
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 188 
Induction of ER stress by glucose starvation- Panc-1 cells were maintained in DMEM 189 
supplemented with 10% fetal bovine serum and then switched to glucose-free DMEM medium 190 
(cat# 11966-025, life technologies) for indicated times. 191 
 192 
Statistical analysis- for assessment of statistical significance, a Student t test was used. P values 193 
of < 0.05 were considered statistically significant. 194 
 195 
 196 
RESULTS 197 
Induction of ER stress leads to reduced ECD protein expression in a PERK-eIF2α-dependent 198 
manner- To begin to explore the potential link of ECD to ER stress, we asked if the levels of 199 
ECD protein are affected by induction of ER stress. For this purpose, immortal human mammary 200 
epithelial cell line MCF-10A was treated with Thapsigargin or Tunicamycin, two commonly 201 
used chemical ER stress inducers (63), and ECD protein levels were analyzed by western 202 
blotting. Treatment with both ER stress inducers increased the level of p-eIF2α as expected (63) 203 
(Fig. 1A&B). Notably, a concomitant time-dependent decrease in ECD protein levels was 204 
observed upon treatment with either Thapsigargin (Fig. 1A) or Tunicamycin (Fig. 1B).  205 
Given the effect of chemical ER stress inducers on ECD protein levels, we next assessed whether 206 
physiological stress such as glucose starvation would have similar effects.  For this purpose, we 207 
used human pancreatic carcinoma cell line (Panc-1) which is known to exhibit ER stress upon 208 
glucose starvation (63).  Significantly, similar to chemical ER stress, glucose starvation-induced 209 
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ER stress also exhibited a reduced levels of ECD protein(Fig. 1C). To assess whether the 210 
decrease in ECD protein levels was due to reduced ECD mRNA levels, we measured ECD 211 
mRNA levels using qRT-PCR. Induction of CHOP mRNA was used as a control (Fig. 1D). 212 
Notably, ECD mRNA levels were not only not reduced but in fact showed an increase (Fig. 1E), 213 
suggesting that the reduction in ECD protein level was not at the transcriptional level; likewise, 214 
physiological stress by glucose starvation also increased ECD mRNA levels (Fig. 1F). Since 215 
PERK activation and subsequent phosphorylation of eIF2α mediates translational block in 216 
response to ER stress (24), we used MEFs in which this pathway is genetically abrogated. First, 217 
we treated Wild-Type (WT) MEFs or MEFs from PERK kinase domain knockout (PERK-KO) 218 
mice (64) with Thapsigargin and analyzed ECD protein levels  by western blotting. The expected 219 
lack of PERK pathway activation in PERK-KO MEFs was confirmed by lack of induction of 220 
PERK phosphorylation in PERK-KO MEFs compared to WT MEFs (Fig.1G). Significantly, 221 
while a decrease in ECD protein levels was observed in WT MEFs treated with Thapsigargin, the 222 
levels of ECD protein were unchanged in PERK-KO MEFs (Fig. 1G). Then, ECD mRNA were 223 
assessed in PERK KO and control MEFs to determine whether the levels are altered upon 224 
Thapsigargin treatment. Again, CHOP mRNA induction was used as a positive control (Fig. 1H). 225 
As expected, in PERK KO MEFs, CHOP mRNA is very minimally induced upon Thapsigargin 226 
treatment as compared to control cells (Fig. 1H), since CHOP is downstream of PERK (24-32). 227 
Notably, while ECD mRNA increased in control WT MEFs, in PERK KO MEFs, induction of 228 
ECD mRNA is low as compared to control WT PERK MEFs (Fig. 1I).  229 
To further examine the role of the PERK pathway in the downregulation of ECD protein 230 
expression, we utilized MEFs from mice that carry a serine 51 to alanine mutation in eIF2α 231 
which prevents its phosphorylation by activated PERK and makes the cells resistant to PERK-232 
 o
n
 June 29, 2017 by UNIV O
F NEBRASKA M
ED CTR
http://m
cb.asm
.org/
D
ow
nloaded from
 
 
 
12 
 
mediated translation block upon ER stress induction (59). As expected, the levels of p-eIF2α 233 
increased in WT MEFs but not in the phospho-deficient eIF2α mutant MEFs when ER stress was 234 
induced with Thapsigargin or Tunicamycin (Fig. 1J, compare lanes 1-3 with lanes 4-6). 235 
Importantly, while ECD protein levels decreased in WT MEFs treated with ER stress inducers 236 
(Fig. 1J, compare lane 1 to lanes 2-3), the levels of ECD protein did not change in identically-237 
treated mutant eIF2α MEFs (Fig. 1J compare lane 4 to lanes 5-6). Together, these results support 238 
a conclusion that ECD protein levels are downregulated upon ER stress in a PERK-eIF2α 239 
dependent manner, and that ER stress upregulates ECD mRNA levels, suggesting a regulatory 240 
link between ECD and the PERK pathway of ER stress. 241 
 242 
ECD co-localizes and associates with PERK and GRP78- To further explore a potential link 243 
between ECD and the ER stress pathway, we assessed the localization of ECD. We first 244 
performed immunofluorescence using Super-resolution Structured Illumination Microscopy 245 
(SIM), a technique that offers a much higher resolution than conventional confocal microscopy 246 
(65,66). Co-localization of PERK and GRP78 served as a positive control since PERK and 247 
GRP78 are known interacting partners (13). Indeed, we observed that endogenous PERK and 248 
GRP78 were co-localized in a punctate distribution (Fig. 2A). Significantly, ECD also co-249 
localized with PERK and GRP78 (Fig. 2B & C), although not as extensive as GRP78-PERK co-250 
localization. Negative controls rabbit and mouse IgGs showed no staining (Fig. 2 D & E).  Next, 251 
we performed sub-cellular fractionation of MCF-10A cells to biochemically assess the ER 252 
localization of ECD. This analysis showed expected presence of ECD in the soluble fraction 253 
(40,42). Importantly, ECD was prominently present in the ER-containing microsomal fraction 254 
(Fig. 2F). Given the co-localization of ECD with PERK and GRP78 (Fig. 2A-C), we assessed if 255 
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ECD associates with PERK and/or GRP78. First, we used PLA to assess the proximity of ECD 256 
relative to GRP78 and PERK in MCF-10A cells. Known ECD interaction with 257 
PIH1D1component of the R2TP served as positive control (42,46). Indeed, ECD and PIH1D1 258 
formed distinct foci detectable by PLA (Fig. 2G, red dots). Significantly, PLA signals were also 259 
observed for ECD and GRP78 or ECD and PERK (Fig. 2H-I). Finally, we carried out 260 
immunoprecipitation (IP) of ECD from lysates from MCF-10A cell, treated or left untreated with 261 
Thapsigargin, followed by western blotting for PERK and GRP78 antibodies to assess their 262 
association. IP of ECD co-immunoprecipitated PIH1D1 (Fig. 2K), as expected based on known 263 
interaction of ECD with PIH1D1 (42,46). Importantly, PERK and GRP78 also co-264 
immunoprecipitated with ECD (Fig. 2K, left panel). A reverse IP of GRP78 also co-265 
immunoprecipitated ECD, with PERK used as a positive control (Fig. 2K right panel). Taken 266 
together, these results suggest that ECD associates with PERK and GRP78. 267 
 268 
ECD regulates the PERK arm of the UPR- The association of ECD with PERK and GRP78 269 
(Fig. 2) and abrogation of the decrease in ECD levels in PERK KO cells upon ER stress (Fig.1) 270 
suggested that ECD may be functionally linked to UPR through PERK pathway. Therefore, we 271 
assessed the activation of the PERK pathway in the absence or presence of UPR inducers in cells 272 
in which ECD could be inducibly deleted. For this purpose, we utilized Ecdfl/fl MEFs which have 273 
been previously established and shown to exhibit Ecd gene deletion and loss of ECD protein 274 
expression upon infection with adenovirus expressing Cre recombinase (41). Previously, we 275 
have observed that induction of Ecd deletion in these Ecdfl/fl MEFs, aside from inducing cell 276 
cycle arrest, led to a decrease in cell survival even in the absence of any stress (41,42).  277 
 o
n
 June 29, 2017 by UNIV O
F NEBRASKA M
ED CTR
http://m
cb.asm
.org/
D
ow
nloaded from
 
 
 
14 
 
Notably, Cre-meditated deletion of Ecd in the Ecdfl/fl MEFs led to an increase in the levels of 278 
phospho-PERK (p-PERK) and p-eIF2α, when compared to control adeno-GFP infected MEFs 279 
(Fig. 3A, compare lane 1 with 3), and these effects were further enhanced by treatment with 280 
Thapsigargin (Tg), the inhibitor of the Sarco/Endoplasmic Reticulum Calcium ATPase (Fig. 3A, 281 
compare lane 2 with 4). Spliced XBP1 also showed some increase in ECD null cells upon 282 
Thapsigargin treatment while ATF6 did not show a significant change (Fig. 3A). Consistent with 283 
the increased p-PERK levels upon ECD deletion, Thapsigargin treated ECD-depleted MEFs also 284 
exhibited increased expression of CHOP mRNA (Fig. 3B), a downstream effector of the PERK 285 
pathway whose target genes promote cell death (24-28,30,31). The increased CHOP mRNA 286 
correlated with an increased cleaved caspases 3 in ECD null cells (Fig. 3C, compare lane 2 with 287 
4) and a significant reduction in cell survival, as measured by colony-forming assays (Fig. 3D). 288 
To further assess these effects, we used physiological stress in Panc-1 cells (Fig. 3E) in which 289 
ECD was knocked down followed by glucose starvation. Again, here too,  a siRNA knock down 290 
of ECD plus glucose starvation led to an enhanced eIF2α phosphorylation, the downstream target 291 
of PERK, and increased cleaved caspase 3 as compared to control cells (Fig. 3E, compare lanes 292 
1-5 with lanes 6-10), suggesting more cell death in ECD-knocked down cells upon glucose 293 
starvation.  294 
In a reciprocal approach, we overexpressed ECD and then examined its impact on the UPR, in 295 
particular the PERK pathway, upon ER stress induction. To this end, we generated MEFs from 296 
mice that carry a Doxycycline (Dox)-inducible Ecd transgene ((Tet(O)-Flag-hECD-IRES-eGFP; 297 
rtTA)) or a control transgenic mouse without rtTA ((Tet(O)-Flag- hECD-IRESeGFP)). These 298 
MEFs were treated with Dox to induce ECD overexpression, followed by treatment with 299 
Thapsigargin. As expected, control MEFs exhibited an increase in p-PERK and CHOP mRNA; 300 
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however, the MEFs with Dox-induced ECD overexpression exhibited a substantially reduced 301 
level of p-PERK and CHOP mRNA upon Thapsigargin treatment as compared to control MEFs 302 
(Fig. 3F & G). Likewise, when the MEF cell lines were treated with Thapsigargin for various 303 
time points (3, 6, 12 or 24h), ECD over-expressing MEFs exhibited lower levels of p-PERK 304 
compared to those in control MEFs (Fig. 3H, compare lanes 1-5 with lanes 6-10).  A 305 
corresponding reduction in the levels of ATF4, a downstream target of PERK signaling, was 306 
seen in ECD over-expressing MEFs compared to their control MEFs (Fig. 3H, compare lanes 3-5 307 
with lanes 8-10); s-XBP1 and ATF6 also were slightly reduced in ECD over-expressing MEFs 308 
(Fig. 3H, compare lanes 1-5 with lanes 6-10). Importantly, ECD overexpression was associated 309 
with a substantially higher level of GRP78 following Thapsigargin treatment as compared to 310 
control MEFs (Fig. 3H compare lanes 2-5 to lanes 7-10); GRP94 protein and PDI, two other 311 
chaperones, were also slightly increased in ECD over-expressing MEFs but not as dramatically 312 
increased as GRP78 upon Thapsigargin treatment (Fig. 3H compare lanes 1-5 to lanes 6-10). 313 
Similar to Thapsigargin, induction of ER stress with Tunicamycin, which induces ER stress by 314 
inhibiting glycosylation of proteins in the ER, was also associated with lower levels of p-PERK 315 
and p-eIF2α in ECD overexpressing MEFs as compared to control MEFs (Fig. 3I compare lanes 316 
2-5 with lanes 7-10). Furthermore, higher levels of GRP78 protein was also observed in ECD 317 
overexpressing MEFs as compared to control MEFs upon Tunicamycin treatment (Fig. 3I 318 
compare lanes 2-5 with lanes 7-10). Taken together, these results strongly support a conclusion 319 
that ECD negatively regulates PERK signaling while enhancing the adaptive capacity of the cells 320 
by increasing levels of chaperones, predominantly, GRP78 protein in response to ER stress.  321 
The increased induction of GRP78 is required for ECD to attenuate PERK signaling- 322 
Induction of GRP78 expression during ER stress is a homeostatic mechanism to reduce the 323 
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unfolded protein load in the ER, thereby reducing the activation of UPR sensors. As a major 324 
regulator of PERK, overexpression of GRP78 has been shown to reduce PERK signaling upon 325 
ER stress induction (13). Given the enhanced induction of GRP78, together with attenuation of 326 
PERK signaling in ECD overexpressing MEFs exposed to ER stress (Fig. 3H-I), we examined 327 
the possibility that the increased GRP78 levels upon ECD overexpression may be 328 
mechanistically linked to the reduction of PERK signaling. To investigate this possibility, we 329 
first examined changes in the levels of GRP78 in ECD deleted MEFs where we observed 330 
increased PERK phosphorylation (Fig. 3A). To assess if ECD was required for optimal GRP78 331 
protein levels upon ER stress, we exposed the wild-type MEFs or MEFs with Ecd deletion 332 
induced by adeno-Cre (as in Fig. 3A-D) to Thapsigargin, and then assessed the levels of GRP78 333 
protein, at various time points, by western blotting. The levels of GRP78, over time, were 334 
reduced in ECD-null MEFs compared to GRP78 levels in control MEFs (Fig. 4A, compare lanes 335 
3-5 with 8-10). Likewise, using physiological stress, a knock down of ECD in Panc-1 cells led to 336 
a decrease in GRP78 levels upon glucose starvation (Fig. 4B, compare lanes 1-5 with lanes 6-337 
10). To examine whether the reduced induction of GRP78 in ECD-null MEFs was a result of 338 
reduced GRP78 mRNA expression, we carried out qPCR analyses of mRNA isolated from WT 339 
or Ecd-null MEFs treated with Thapsigargin. As expected, GRP78 mRNA levels increased in 340 
WT MEFs upon Thapsigargin treatment (Fig. 4C); however, the levels of GRP78 mRNA 341 
induction in Ecd-null MEFs was comparable to that in control MEFs (Fig. 4C). Similarly, 342 
GRP78 mRNA levels in control vs. ECD over-expressing MEFs treated with Thapsigargin were 343 
comparable (Fig. 4D). To determine whether GRP78 may be less stable in ECD null cells, we 344 
first knocked down ECD in Panc-1 cells, which have high level of GRP78, followed by 345 
inhibition of protein synthesis by cycloheximide treatment over various time points and GRP78 346 
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protein levels were analyzed by western blot. Significantly, the time dependent decrease in 347 
GRP78 protein levels following cycloheximide treatment was faster in ECD-knocked down cells 348 
compared to their control cells (Fig. 4E).  Next, to examine the possibility that ECD 349 
overexpression is associated with increased GRP78 protein stability, control or ECD over-350 
expressing cells were treated with Thapsigargin to induce GRP78 protein, followed by 351 
cycloheximide (CHX) treatment over various time points. Notably, the time-dependent decrease 352 
in GRP78 levels was slower in ECD over-expressing MEFs as compared to control MEFs (Fig. 353 
4F). Finally, to determine whether the increase in GRP78 protein levels upon ECD 354 
overexpression was required for the attenuation of PERK activation seen upon ER stress 355 
induction, we depleted GRP78 using siRNA in both control and ECD overexpressing MEFs 356 
followed by Thapsigargin treatment. Notably, the attenuating effect of ECD overexpression on 357 
PERK phosphorylation upon Thapsigargin treatment was abrogated by GRP78 knockdown (Fig. 358 
4G; compare lane 5-6 with 7-8). Taken together, these results support the conclusion that ECD 359 
positively regulates GRP78 protein level upon ER stress induction to attenuate PERK activation. 360 
  361 
ECD overexpression protects cells from ER stress-induced cell death- ER stress response is 362 
initially aimed at the survival of cells (67); however severe ER stress shifts the response from a 363 
pro-survival to a pro-apoptotic response (23,31) through PERK-mediated induction of CHOP 364 
expression, a transcription  factor that enhances the expression of pro-apoptotic pathway genes 365 
(24-28,30,31,68). Several studies found that inhibition/attenuation of the PERK pathway 366 
protected cells against stress-induced cell death (69-72). Given our observations that ECD 367 
functions as a modulator of PERK signaling, we assessed if the levels of ECD determine a 368 
differential survival vs. apoptotic cell fate upon ER stress induction. For that purpose, we treated 369 
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control MEFs or Dox-inducible ECD overexpressing MEFs with Thapsigargin and then assessed 370 
the level of apoptosis induction by examining caspase 3 cleavage (73). As anticipated, a 371 
Thapsigargin dose-dependent increase in cleaved caspase 3 levels was observed in control 372 
MEFs, whereas the levels of cleaved caspase 3 were markedly lower in ECD-overexpressing 373 
MEFs (Fig. 5A). Real-time qPCR analyses demonstrated that Thapsigargin-induced expression 374 
of CHOP, a PERK-regulated mediator of cell death (24-28,30-32), was lower in ECD 375 
overexpressing MEFs as compared to control MEFs (Fig. 5B). To further assess the pro-survival 376 
effects of ECD against apoptotic cell fate upon ER stress induction, we assessed the abilities of 377 
control vs. ECD-overexpressing MEFs to form colonies after their exposure to ER stress. For this 378 
purpose, equal numbers of control or ECD overexpressing MEFs were treated with Thapsigargin 379 
for 24h, and the cells were maintained in Thapsigargin-free medium for 10 days followed by 380 
crystal violet staining and counting of surviving colonies. Notably, more colonies were observed 381 
in ECD overexpressing MEFs as compared to control MEFs (Fig. 5C), further supporting the 382 
conclusion that ECD provides survival advantage upon ER stress. 383 
 384 
DISCUSSION 385 
The ER-localized stress response pathway referred to as the UPR is a well-conserved 386 
response to a number of cellular stresses such as unfolding of proteins in the ER. The UPR elicits 387 
a spectrum of downstream responses whose outcomes range from restoration of homeostasis to 388 
cellular apoptosis if the stress is extreme and prolonged (23,31). The UPR thus represents a 389 
double-edged sword and must be intricately regulated to prevent inappropriate cellular outcomes. 390 
Mechanisms that help modulate the magnitude and type of the UPR in response to physiological 391 
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or pathological stress stimuli are not fully understood.  In this study, we provide evidence that 392 
ECD protein is a negative regulator of the PERK arm of the UPR through GRP78. 393 
Several lines of circumstantial evidence discussed in the Introduction section suggested a 394 
potential involvement of ECD in UPR but direct support for such a role has been lacking. We 395 
established that induction of ER stress, using both chemical ER stress inducers (Thapsigargin 396 
and Tunicamycin) and physiological ER stressors (glucose starvation), leads to downregulation 397 
of ECD protein levels while the mRNA levels were elevated (Fig. 1A-F). By using PERK kinase 398 
knockout (KO) or phosphorylation-deficient eIF2α MEFs (Fig. 1G-J), we established that ECD 399 
was linked to the PERK pathway of the UPR. The association of ECD with PERK and GRP78 400 
(Fig. 2) further linked ECD to the PERK arm of the UPR. A functional connection of ECD to the 401 
PERK arm of the UPR is supported by the distinct modulation of the PERK-mediated responses 402 
elicited by perturbations of the cellular levels of ECD. Depletion of ECD sensitized cells to 403 
PERK signaling in response to ER stress, with increase in p-PERK and p-eIF2α levels, as well as 404 
an increase in the downstream effector of PERK, the transcription factor CHOP, leading to a 405 
reduced survival of these ECD depleted MEFs (Fig. 3A-E). Reciprocally, upregulation of ECD 406 
reduced PERK signaling upon induction of ER stress (Fig. 3F-I). As activation of the PERK 407 
pathway promotes cell death in response to ER stress, primarily through CHOP-dependent 408 
expression of pro-apoptotic genes (24-32) and abrogation of PERK signaling protects cells 409 
against stress-induced cell death (69-71), our results supported the likelihood that ECD functions 410 
to modulate PERK pathway activity and promote cell survival during ER stress. Indeed, 411 
assessment of cellular survival in response to ER stress showed that reduction in ECD levels 412 
impaired cell survival to ER stress (Fig. 3C-E) while overexpression of ECD promoted cell 413 
survival (Fig. 5). Collectively, these results support the conclusion that ECD and PERK are 414 
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linked through a negative feedback mechanism whereby ECD exerts an inhibitory effect on 415 
PERK pathway signaling whereas activated PERK in turn reduces ECD protein levels via eIF2α-416 
dependent translational block. Consistent with a reciprocal negative feedback relation between 417 
ECD and PERK, activated PERK negatively regulates cell growth (33-35); conversely,  ECD 418 
positively regulates cell growth (41) and is overexpressed in human breast and pancreatic cancer 419 
specimens, correlating with poor prognostic markers and shorter survival (57,74).  While the 420 
physiological benefit of an increased ECD mRNA upon ER stress is not yet understood, a 421 
speculation is that this effect may reflect a feedback response to the decrease in ECD protein 422 
levels to compensate for the loss of ECD but ECD translation is blocked. Although ECD has 423 
been reported to play roles in pre-mRNA splicing in drosophila (75), it is unlikely that ECD 424 
alters its own mRNA splicing upon ER stress because ECD protein levels decrease upon ER 425 
stress. 426 
Modulation of ECD levels using knockdown or overexpression demonstrated that ECD is 427 
a positive regulator of GRP78 levels (Fig. 3H-I; Fig 4.). While slight increases in GRP94 and 428 
PDI were observed, the effect on GRP78 was more dramatic. As increased expression of GRP78 429 
and other chaperones is known to promote the clearing of ER stress-causing unfolded protein 430 
load and reduce the activation of UPR sensors (13-15,55), we surmised that upregulation of 431 
GRP78 and other chaperones (Fig. 3H) may represent one potential mechanism by which ECD 432 
negatively regulates the PERK pathway activation and relieves ER stress. Indeed, knockdown of 433 
GRP78 eliminated the ability of overexpressed ECD to attenuate PERK pathway signaling (Fig. 434 
4G). Notably, GRP78 is required for cell survival not only in response to ER stress (76-79) but 435 
also in other stressful and hostile conditions such as glucose deficiency encountered in tumor 436 
microenvironment (80-85). Given that the PERK arm of the UPR is also activated in cancer 437 
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(68,86,87) and both ECD and GRP78 are overexpressed in cancer (57,74,80-85), we suggest that 438 
ECD overexpression may play a similar role to mitigate the negative consequences of elevated 439 
PERK signaling found in cancer. Given the mechanistic link between ECD and GRP78 in 440 
inhibiting the PERK pathway to promote cell survival, it will be of great interest to explore if 441 
GRP78 and ECD are co-overexpressed in tumors that use the UPR to promote tumor cell 442 
survival and hence may be suitable targets for UPR-directed therapeutic agents. 443 
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Figure 1. Induction of ER stress leads to reduced ECD protein expression in a PERK-458 
eIF2α-dependent manner. (A-C): MCF-10A cells were treated with Thapsigargin (50 nM, A) 459 
or Tunicamycin (50 ng/ml, B); Panc-1 (C) were cultured in glucose-free medium and then cell 460 
lysates were prepared at the indicated time points. Equal amount of proteins was resolved on 461 
SDS-PAGE followed by western blotting with indicated antibodies. Increase in the levels of p-462 
eIF2α served as marker for induction of ER stress. (D-F): MCF-10A cells were treated with 463 
Thapsigargin (D-E) and Panc-1 cells were cultured in glucose-free medium (F), then total RNA 464 
was isolated followed by qRT-PCR using CHOP primers and ECD primer (Mean +/- SD and p-465 
values are shown from 3 independent experiments * p<0.05). CHOP mRNA induction served as 466 
control for Thapsigargin-induced ER stress. (G): Wild-type (WT) PERK and PERK kinase 467 
domain knockout (PERK-KO) MEFs were treated with Thapsigargin (50 nM) for 14 h and then 468 
cell lysates were resolved on SDS-PAGE gels followed by western blot with indicated 469 
antibodies. (H-I): PERK KO and control WT MEFs were treated with Thapsigargin and total 470 
RNA was isolated at indicated time points followed by qRT-PCR with primers against CHOP 471 
(Fig. H) or ECD (Fig. I). (J): WT eIF2α MEFs or mutant eIF2α phospho-deficient MEFs were 472 
treated with Thapsigargin (Tg, 50 nM) or Tunicamycin (Tun, 50 ng/ml) for 14 h and then cell 473 
lysates were analyzed by western blotting with indicated antibodies. 474 
 475 
 Figure 2: ECD co-localizes and associates with PERK and GRP78.  (A-E): Immortal MEFs 476 
were fixed in 3% paraformaldehyde (PFA) and stained with indicated antibodies and mounted 477 
for analyses with structure-illuminated microscopy (SIM).  PERK and GRP78 co-localization 478 
served as positive control. DAPI was used to stain the nucleus. (F): MCF-10A cells were 479 
fractionated into soluble and microsomal fractions. The purity of the fractions was assessed by 480 
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GAPDH (a marker for the soluble/cytoplasmic fraction), PERK and SERCA (both markers for 481 
microsomal fraction) and RCAS1 (a Golgi-predominant protein) (88). (G-J): MCF-10A cells 482 
were fixed with 3% PFA and stained with indicated antibodies (all antibodies were generated in 483 
rabbit except anti-ECD mouse antibody) followed by species-specific secondary antibodies 484 
linked to complementary DNA probes to allow fluorescent probe-based detection of the PCR 485 
amplification product as distinct foci. Incubation with Proximity Ligation Assay plus and minus 486 
probes, followed by ligation and amplification, was carried out according to the manufacturer 487 
protocol. Red dots indicate interaction. ECD and PIH1D1 served as positive control. (K): Lysates 488 
from MCF-10A cells, treated or left un-treated with Thapsigargin, were subjected to IP with anti-489 
ECD antibody (left panel) or anti-GRP78 (right panel) followed by Western blotting with 490 
indicated antibodies. ECD and PIH1D1(left panel) or GRP78 and PERK (right panel) served as 491 
positive controls. 492 
 493 
Figure 3. ECD regulates the PERK pathway of the UPR. (A & C): Ecd fl/fl MEFs were 494 
infected with adenoviruses coding for GFP (adeno-GFP for control) or Cre (adeno-Cre) for 72h. 495 
The cells were then left un-treated or treated with Thapsigargin (50 nM). Equal amount of 496 
proteins was resolved on SDS-PAGE gel followed by western blotting with indicated antibodies.   497 
(B): After adenoviruses infection as described in (A), cells were treated with Thapsigargin. Total 498 
RNA was isolated followed by qRT-PCR with CHOP primers; Mean +/- SD and p-values from 3 499 
independent experiments are indicated * p<0.05. (D): After adenoviruses infection as described 500 
in (A), equal number (1,000) of wild-type (WT) or ECD-/- cells were plated in triplicate and 501 
treated with Thapsigargin for 24h. 10 days later, surviving colonies were assessed after crystal 502 
blue (0.5% in 25% Methanol) staining. The color retained after the wash was dissolved in 10% 503 
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acetic acid and the absorbance was read at 590 nm. The graph below represents the relative 504 
absorbance; Mean +/- SD and p-values from 4 independent experiments are indicated * p<0.05; 505 
** p≤0.002. (E): Panc-1 cells were treated with control or ECD siRNA for 48h. Then, the cells 506 
were switched to glucose-free media and cell lysates were prepared at indicated time points 507 
followed by western blot with indicated antibodies. (F; H-I): ECD inducible MEFs [(Tet(O)-508 
Flag- hECD-IRESeGFP;rtTA)]  or control MEFs [(Tet(O)-Flag- hECD-IRESeGFP)] were treated 509 
with Dox for 48 h followed by treatment with Thapsigargin (50 nM) or Tunicamycin (50 ng/ml). 510 
Cell lysates were prepared at indicated time points and equal amount of proteins was resolved on 511 
SDS-PAGE gel followed by western blot with indicated antibodies. (G): Following ECD 512 
induction and Thapsigargin treatment as described above, CHOP mRNA levels were assessed 513 
using qRT-PCR. 514 
 515 
Figure 4. The increased induction of GRP78 expression is required for ECD to 516 
downregulate PERK signaling. (A): Ecd fl/fl MEFs were treated with adenovirus as described in 517 
(Fig. 3A-C) and then the cells were treated with Thapsigargin (50 nM). Cell lysates were 518 
prepared at the indicated time points. Equal amount of proteins was resolved on SDS-PAGE gel 519 
followed by western blotting with indicated antibodies. (B): ECD was knocked down by siRNA 520 
(20 nM) in Panc-1 cells followed by exposure to glucose-free media and cell lysates were 521 
collected at indicated times points followed by western blot with indicated antibodies. (C-D): 522 
Following ECD deletion (C) or ECD overexpression (D) and Thapsigargin treatment as 523 
described above, the levels of GRP78 mRNA were assessed in WT (control) vs. ECD-/- (Cre-524 
adenovirus treated) or control vs. ECD over-expressing MEFs using qRT-PCR. (E): ECD was 525 
knocked down in Panc-1 cells followed by cycloheximide treatment (25 uM). Cell lysates were 526 
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prepared at indicated time points followed by western blot with indicated antibodies. (F): ECD 527 
inducible MEFs and their control MEFs were treated with Dox, as described previously, 528 
followed by treatment with Thapsigargin and then Cycloheximide treatment (25 uM) for 529 
indicated time points. Cell lysates were prepared followed by western blotting with indicated 530 
antibodies. (G): ECD overexpressing and their control MEFs were treated with GRP78 SiRNA 531 
(30 nM) or control siRNA (scrambled). 24 h later, the cells were treated with Dox for 48 h to 532 
induce ECD overexpression followed by Thapsigargin treatment (50 nM). Equal amount of 533 
proteins was resolved on SDS-PAGE gel followed by western blotting with indicated antibodies. 534 
 535 
Figure 5. ECD overexpression provides survival advantage. (A): ECD was induced as 536 
described in (Fig. 3 and 4) followed by Thapsigargin treatment for 24 h. Equal amount of 537 
proteins was resolved on SDS-PAGE gel followed by western blot with indicated antibodies. 538 
(B): Following ECD induction with Dox and Thapsigargin treatment as described above, total 539 
RNA was isolated and CHOP mRNA was assessed by qPCR; Mean +/- SD and p-values from 3 540 
independent experiments are indicated * p<0.05. (C): After ECD induction, control and ECD 541 
inducible MEFs were trypsinized and equal number of cells (1,000) were plated in triplicates. 8 h 542 
later, the cells were treated with Thapsigargin for 24h. 10 days later, surviving colonies were 543 
assessed by Crystal blue staining (0.5% in 25% Methanol). The color retained after the wash was 544 
dissolved in 10% Acetic acid and the absorbance was read at 590 nm. The graph below 545 
represents the relative absorbance; Mean +/- SD and p-values from 4 independent experiments 546 
are indicated ** p≤0.002. 547 
  548 
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A Novel Interaction of Ecdysoneless (ECD) Protein with R2TP
Complex Component RUVBL1 Is Required for the Functional Role of
ECD in Cell Cycle Progression
Riyaz A. Mir,a Aditya Bele,a Sameer Mirza,a Shashank Srivastava,a Appolinaire A. Olou,a Shalis A. Ammons,a Jun Hyun Kim,a*
Channabasavaiah B. Gurumurthy,a Fang Qiu,g Hamid Band,a,b,c,d,e,f Vimla Banda,f
Departments of Genetics, Cell Biology, and Anatomy,a Pathology and Microbiology,b Pharmacology and Experimental Therapeutics,c and Biochemistry and Molecular
Biology,d College of Medicine, Eppley Institute for Research in Cancer and Allied Diseases,e Fred and Pamela Buffett Cancer Center,f and Department of Biostatistics,
College of Public Health,g University of Nebraska Medical Center, Omaha, Nebraska, USA
Ecdysoneless (ECD) is an evolutionarily conserved protein whose germ line deletion is embryonic lethal. Deletion of Ecd in cells
causes cell cycle arrest, which is rescued by exogenous ECD, demonstrating a requirement of ECD for normal mammalian cell
cycle progression. However, the exact mechanism by which ECD regulates cell cycle is unknown. Here, we demonstrate that ECD
protein levels and subcellular localization are invariant during cell cycle progression, suggesting a potential role of posttransla-
tional modifications or protein-protein interactions. Since phosphorylated ECDwas recently shown to interact with the PIH1D1
adaptor component of the R2TP cochaperone complex, we examined the requirement of ECD phosphorylation in cell cycle pro-
gression. Notably, phosphorylation-deficient ECDmutants that failed to bind to PIH1D1 in vitro fully retained the ability to
interact with the R2TP complex and yet exhibited a reduced ability to rescue Ecd-deficient cells from cell cycle arrest. Biochemi-
cal analyses demonstrated an additional phosphorylation-independent interaction of ECDwith the RUVBL1 component of the
R2TP complex, and this interaction is essential for ECD’s cell cycle progression function. These studies demonstrate that interac-
tion of ECDwith RUVBL1, and its CK2-mediated phosphorylation, independent of its interaction with PIH1D1, are important
for its cell cycle regulatory function.
Precisely regulated cell proliferation is essential for embryonicdevelopment as well as homeostasis in adult organs and tis-
sues, whereas uncontrolled cell proliferation is a hallmark of can-
cer (1). Amore in-depth understanding of the regulatory controls
of cell cycle progression is therefore of great interest.
The Ecd genewas originally inferred from studies ofDrosophila
melanogaster ecdysoneless (or ecd) mutants that exhibit defective
development due to reduced production of the steroid hormone
ecdysone (2). Subsequent cloning of drosophila ecd helped iden-
tify a cell-autonomous role of ECD protein in cell survival aside
from its non-cell-autonomous role in ecdysis (molting) (3). How-
ever, themolecular basis of howECD functions remains unknown
(3). The human ECD homologue was initially identified in a
screen of human open reading frames that complemented the S.
cerevisiaemutants lackingGcr2 (glycolysis regulation 2) gene, and
it rescued the growth defect caused by reduced glycolytic enzyme
activity inGcr2mutants. The human gene was initially designated
HSGT1 (human suppressor of Gcr2) and was suggested to func-
tion as a coactivator of glycolytic gene transcription (4). However,
ECD protein bears no structural homology to Gcr2, and a true
ECD orthologue is absent in S. cerevisiae, suggesting that ECD
likely functions by distinct mechanisms.
We identified human ECD in a yeast two-hybrid screen of hu-
man mammary epithelial cell cDNA-encoded proteins for novel
binding partners of the human papillomavirus 16 (HPV16) E6
oncogene (5).We showed that deletion of Ecd gene inmice causes
embryonic lethality, identifying an essential role of ECD during
early embryonic development (6). Notably, Cre-mediated condi-
tional deletion of Ecd in Ecdfl/fl mouse embryonic fibroblasts
(MEFs) led to a G1/S cell cycle arrest, and this phenotype was
rescued by the ectopic expression of human ECD (6), indicating
an essential role of ECD in promoting cell cycle progression. We
showed that ECD can interact with the retinoblastoma (RB) pro-
tein and reduces the repression of RB onE2F transcription factors,
providing a novel mechanism by which ECD functions as a posi-
tive factor ofmammalian cell cycle progression (6). Recently, ECD
was shown to play a vital role in pre mRNA splicing by interacting
with the pre-mRNA-processing-splicing factor 8 (PRPF8) (7).We
and others have shown that ECD shuttles between nucleus and the
cytoplasm, with a predominantly cytoplasmic steady-state local-
ization due to rapid nuclear export (7, 8). Consistent with these
key cellular roles of ECD, we found that ECD is significantly over-
expressed in breast and pancreatic cancers, and its overexpression
correlates positively with poor prognostic factors and poor patient
survival (9, 10).
A pulldown screen using the phospho-peptide-binding do-
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main of PIH1D1, the adaptor component of the evolutionarily
conserved prefoldin-like cochaperone complex R2TP, recently
identified ECD as one of the binding partners (11). This interac-
tion was shown to require dual phosphorylation of Ser-505 and
Ser-518 on ECD (11), suggesting that ECD phosphorylation may
mediate its interaction with the R2TP complex. To date, this in-
teraction has not been demonstrated in the context of endogenous
ECDnor has a functional role of this interaction been determined.
The core R2TP complex is composed of four proteins: PIH1D1,
RPAP3, RUVBL1, and RUVBL2 (each with a number of other
names) (12). The R2TP complex is involved in the assembly of
multisubunit complexes, including the small nucleolar ribo-
nucleoproteins, RNA polymerase II, and phosphatidylinositol
3-kinase-related kinases and their complexes (13–15). As such, the
R2TP complex is involved in a number of essential cellular pro-
cesses. The closely related RUVBL1 and RUVBL2 proteins are
AAA (ATPases associated with diverse cellular activities) that
are essential for R2TP function (16). Recent studies have shown
that RUVBL1 (Pontin) plays an important role in cell cycle regu-
lation (17, 18). Germ line deletion ofRuvbl1was shown to be early
embryonic lethal (18, 19). Depletion of RUVBL1 in AML1-ETO
fusion oncogene-expressing leukemic cells was shown to cause
cell cycle arrest (17) and Cre-mediated deletion of Ruvbl1 in
Ruvbl1fl/fl cells also led to G1/S cell cycle arrest (18). The apparent
similarities in the embryonic lethality and cell cycle arrest pheno-
types imparted by the loss of ECD or RUVBL1 expression sug-
gested the likelihood that the recently described interaction with
the R2TP complex (11) may underlie the functional requirement
of ECD in cell cycle progression.
In this study, we extensively analyzed the mechanism of ECD-
R2TP interaction and how disabling this interaction bymutations
in ECD affects the latter’s role in cell cycle progression. We dem-
onstrate that ECD levels and localization do not vary during cell
cycle progression. We show that casein kinase 2 (CK2) phosphor
ylates ECD in cells at 6 major sites and a mutant ECD (6S/A)
disabled for CK2-mediated phosphorylation exhibits reduced
ability to rescue the cell cycle arrest caused by Ecd gene deletion.
Notably, whereas ECD can interact with PIH1D1, loss of this in-
teraction by mutating CK2 phosphorylation sites did not impact
the ECD-R2TP association in cells. We identified a novel interac-
tion of ECD with RUVBL1, independent of ECD’s interaction
with PIH1D1, which we show to be essential for ECD’s cell
cycle progression function. Notably, a phosphomimetic mu-
tant (6S/D) of ECD failed to bindPIH1D1 andwas incompetent at
rescuing the cell cycle arrest caused by Ecd gene deletion, suggest-
ing a potential accessory role for PIH1D1-ECD interaction. Taken
together, our results demonstrate that although CK2-mediated
phosphorylation of ECD is important for its role in cell cycle pro-
gression, ECD’s interaction with PIH1D1 is dispensable, suggest-
ing that the novel RUVBL1-ECD interaction that we identified is
particularly critical for ECD’s function in cell cycle.
MATERIALS AND METHODS
Reagents.  protein phosphatase (catalog no. P9614) was purchased from
Sigma-Aldrich USA, and the treatment was given according to the man-
ufacturer’s instructions. 12.5% SuperSep Phos-tag (50 mol/liter) was
purchased from Wako Laboratory Chemicals (catalog no. 195-16391).
Electrophoresis was performed according to themanufacturer’s protocol.
PreScission protease was purchased from GE Healthcare Life Sciences.
Cell cultures. HEK-293T, MEFs, and T98G glioblastoma cell lines
were grown in DMEM (Life Technologies, Grand Island, NY) supple-
mented with 10% fetal calf serum. Immortal mammary epithelial cell line
76NTERT was cultured in DFCI-1 medium, as described previously (20).
U2OS cell line was cultured in -minimum essential medium (-MEM).
The CK2 inhibitor TBB (4,5,6,7-tetrabromo-2-azabenzimidazole) was
dissolved in dimethyl sulfoxide and used at 50 M.
Plasmid constructs, site-directed mutagenesis, and transfection.
Generation of the pMSCV-puro (Clontech)-based expression constructs
for FLAG-ECD, and its truncated versions has been described previously
(6, 8). The pMSCV-puro construct expressing ECD with deletion of
amino acids 499 to 527 was generated using a thee-fragment ligation into
BglII andHpaI sites. C-terminal His6-tagged ECD truncations (1 to 567, 1
to 534, and 1 to 432) were generated through PCR amplification and
cloning into XbaI and SalI sites of pET-28b vector (Invitrogen), and
recombinant proteins were purified after expression in Escherichia coli
BL21(DE3) strain using a nickel affinity column (GE Healthcare). C-ter-
minal His6-tagged full-length ECDwas generated by cloning ECD coding
sequence into SalI and NotI sites of the pFastBac1 vector (Invitrogen),
expressed in Sf21 insect cells, and purified by using a nickel affinity col-
umn. The PIH1D1-specific and control siRNAs catalog no. Sc-97385;
SantaCruz)were transfected into subconfluent cells usingDharmaFECT1
transfection reagent (Thermo Scientific). Green fluorescent protein
(GFP)-tagged full-length or truncated ECD expression constructs in
the pGEn2 vector were generated by replacing the ST6-Gal1 insert
in the ST6-Gal1-pGEn2 construct (ST6GAL1-pXLG-NtermTCMhis-
Strep-DEST) (21) with PCR-amplified ECD coding sequences at the
EcoRI and HindIII sites by infusion cloning kit (Clontech). The primer
sequences used for cloning are indicated in Table S2 in the supplemental
material. Human PIH1D1 cDNA sequences clone SC321317; Origene)
were subcloned into BamHI and XhoI sites of pGEX-6p-1 for expression
as a glutathione S-transferase (GST) fusion protein in E. coli BL21. A
recombinant GST-PERK kinase domain was expressed in BL21(DE3)
cells purified as a GST fusion protein.
Point mutants of ECDwere generated using a PCR-based commercial
kit (GENEART site-directed mutagenesis system; Invitrogen), according
to the manufacturer’s instructions, cloned into the pET28b vector for
His-tagged recombinant protein expression, and purified by using a
nickel affinity column. The PCR primer sequences are listed in Table S2 in
the supplemental material. All constructs were verified by sequencing.
DNA constructs were transfected in HEK-293T cells using the
X-tremeGENE transfection reagent (Roche). Retroviral infectionwas car-
ried out as described previously (6).
Flow cytometry for cell cycle analysis and biochemical fraction-
ation. 76NTERT cells were plated at 5 105 cells per 100-mm dish for 12
h, subjected to growth factor deprivation by culturing in growth factor-
free DFCI-3 medium for 72 h (20) and released from synchrony using
growth factor-containing DFCI-1 medium (20). Half of the cells were
fixed for fluorescence-activated cell sorter (FACS) analysis after fixation in
chilled 70% ethanol and staining with propidium iodide; the remaining
cells were used for Western blotting. G2/M-to-G1 progression in MEFs
was similarly assessed using FACS analysis after nocodazole (100 ng/ml)-
dependent arrest in the early G2/M phase of cell cycle (22). Nuclear and
cytoplasmic fractions were prepared from cells at various times points
during cell cycle progression using the NE-PER kit (Thermo Scientific,
catalog no. 78833). Ecdflox/floxMEFswere infectedwith adeno-Cre-GFP or
control adeno-GFP to assess the mitotic index. Cells were collected and
fixed as described above. The cell pellet was resuspended in 100 l of
phosphate-buffered saline (PBS) containing 1% bovine serum albumin
(BSA) and 0.25g of phospho-H3-S10 (catalog no. ab14955; Abcam) and
then incubated for 1 h at room temperature. Cells were washed in 150 l
of PBS, resuspended in Alexa Fluor 647 (catalog no. A212235; Life Tech-
nologies)-conjugated goat anti-mouse antibody diluted at a ratio of 1:300
in 100l of PBS containing 1% BSA, and incubated at room temperature
in the dark for 30 min, followed by FACS analysis. The median fluores-
ECD-RUVBL1 Interaction Regulates the Cell Cycle
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cence intensity (MFI) of GFP-positive cells at 488- and 633-nm wave-
lengths was recorded as an indicator ofmitosis in the control and Ecd-null
cells.
Immunoblotting and IP. Cells were lysed in radioimmunoprecipita-
tion assay (RIPA) buffer (20mMTris [pH 7.2], 150mMNaCl, 1% Triton
X-100, 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate [SDS]),
and the protein concentration was measured using the bicinchoninic
acid (BCA) protein assay reagent (Pierce). Immunoblotting was per-
formed with primary antibodies against ECD (9), RB (catalog no.
554136; Pharmingen), anti-phospho-Ser (05-1000; Millipore), anti-
phospho-Thr (AB1607; Millipore), PIH1D1 (sc-101000 or sc-390810;
Santa Cruz), RUVBL1 (12300S [Cell Signaling] or SAB4200194 [Sigma])
RUVBL2 (ab36569; Abcam), RPAP3 (HPA038311; Sigma), PARP (sc-
8007; Santa Cruz), histone H3 (06-755; Millipore), PRPF8 (ab137694;
Abcam), -actin (A5441; Sigma), or -tubulin (T6199; Sigma), as indi-
cated. For immunoprecipitations (IPs), the cells were lysed in NP-40 lysis
buffer (20 mM Tris-HCl [pH 7.5], 200 mM NaCl, 0.5% Nonidet P-40
[NP-40], 1 mM NaF, 0.1 mM Na3VO4, and protease inhibitor mixture
[Roche Applied Science]) and then immunoprecipitated with 3 g of
antibodies against ECD or 35 l of Ezview red anti-FLAG M2 affinity gel
(Sigma) for 2 h to overnight at 4°C. The immune complexes were cap-
tured with protein A/G-agarose (sc-2003; Santa Cruz Biotechnology). To
elute FLAG-tagged proteins from anti-FLAG beads before analysis, im-
mune complexes were incubated with 150 ng of 3 FLAG peptide (Sig-
ma)/l for 15 min at room temperature, and the supernatants were col-
lected for SDS-PAGE. For PIH1D1 interaction with ECD, the cell lysates
were prepared in CHAPS {3-[(3-cholamidopropyl)-dimethylammonio]-
1-propanesulfonate} lysis buffer (0.3% CHAPS, 0.20 mM Tris-HCl [pH
7.4], 120 mMNaCl, 10% glycerol, 5 mMEDTA) supplemented with pro-
tease and phosphatase inhibitor (Roche). RUVBL1 immunoprecipitation
to assess association with ECD was carried out using a monoclonal anti-
RUVBL1 antibody (catalog no. SAB4200194-200UL [Sigma]; 2g). Immu-
noprecipitated RUVBL1 (close to IgG heavy chain) was detected by West-
ern blotting with an anti-RUVBL1 antibody (catalog no. 12300s; Cell
Signaling) that was conjugated to horseradish peroxidase (HRP) using the
Lightning-Link HRP conjugation kit (Novus Biologicals).
In vitro kinase assay. A total of 500 ng of purified recombinant ECD
proteins or its mutants was incubated with 0.2 mM ATP, 1 Ci of [-
32P]ATP (Perkin-Elmer), and 0.2 l (10 U) of human recombinant CK2
(NEB, Beverly, MA) at 30°C for 30 min or as indicated. The reaction was
stopped by adding SDS-PAGE sample buffer. The 32P-labeled proteins
were detected by autoradiography after SDS-PAGE and then transfer to
polyvinylidene difluoride (PVDF) membranes (Millipore). Once the ra-
dioactive signals had decayed, the membranes were blotted with anti-
p-Ser antibodies. Ten nanograms of recombinant GST-PERK kinase
domain was autophosphorylated in kinase assay buffer (50 mM HEPES
[pH 8.0], 10 mMMgCl2, 2.5 mM EGTA) supplemented with 20 M cold
ATP (NEB). Next, 0.5 ng was loaded onto SDS-PAGE gels and subjected
to Western blotting with anti-p-Ser and anti-p-Thr antibodies.
32P metabolic labeling and immunoprecipitation. Exponentially
growing or serum-deprived T98G cells were washed with phosphate-free
Dulbecco modified Eagle medium (DMEM) supplemented with 10% di-
alyzed fetal bovine serum and incubated in the same medium for 1 h
before adding 0.1 mCi of [32P]orthophosphate (NEN) per 10-cm plate.
The cells were labeled for 4 h at 37°C (or for 2, 5, or 16 h for cell cycle
analyses), rinsed once in ice-cold PBS, and lysed in ice-cold lysis buffer
(250mMNaCl, 1%NP-40, 20mMTris-HCl [pH 7.4], 1mMEDTA, 2g
of aprotinin/ml, 2 g of leupeptin/ml, 1 g of pepstatin/ml, 2.5 g of
antipain/ml, 1g of chymostatin/ml, 1 mMNa3VO4, 10 mMNaF, 1 mM
sodium molybdate, 0.5 mM phenylmethylsulfonyl fluoride). Labeled
ECD was immunoprecipitated with affinity-purified mouse anti-Ecd
monoclonal antibody or anti-FLAGbeads overnight at 4°C, andProteinG
Plus/Protein A-agarose beads were added for 1 h. The beads were washed
thee times with ice-cold wash buffer (150 mM NaCl, 1% NP-40, 20 mM
Tris-HCl [pH 7.4], 1 mM EDTA, and protease inhibitors). The immuno-
precipitated proteins were resolved on 7.5% SDS-polyacrylamide gels,
transferred to PVDF membranes, and visualized by autoradiography.
In vitro binding assays. GST-or His-tagged protein pulldowns were
performed as described previously (6). FLAG-tagged wild-type (WT)
ECD or its mutants (3S/A and 6S/A) were expressed by transient transfec-
tion in 293T cells and lysed in CHAPS lysis buffer as described above.
Then, 1,000 g of lysate protein was incubated with 2 g of bead-bound
purified GST-PIH1D1 for 2 h at room temperature, followed by five
washes, and then the bound proteins were detected by Western blotting
with anti-FLAG antibody. Membranes were stained with Ponceau S to
visualize the GST fusion proteins. In vitro tandem affinity purification
(TAP) was performed as described previously (23) using purified recom-
binant ECD with a C-terminal FLAG tag.
Cell proliferationandcolony formationassays.The cell proliferation
was analyzed as described previously (6). Briefly, Ecdflox/flox MEFs were
infected with adenoviruses encoding GFP-Cre or GFP (control) (Univer-
sity of Iowa Gene Transfer Vector Core) and plated at 104 cells/well in
six-well plates, followed by counting of cells at the indicated time points.
For assessing colony formation ability, infected cells were plated at 5,000
or 1,000 per well in six-well plates for 10 days, the colonies were stained
with crystal violet (0.5%crystal violet in 25%methanol) and solubilized in
10% acetic acid, and then the extent of colony formationwasmeasured by
determining the absorbance at 590 nm.
Statistical analysis. A generalized estimating equation method was
used to assess the differences among cell types accounting for the corre-
lated measurement within a sample. Comparisons between the WT and
other cell types at a given time were made with a simulation correction
(random sampling from a probability distribution). Some results were
analyzed using a paired two-tailed Student t test. P values of0.05 were
considered statistically significant.
RESULTS
ECD levels and localization do not change during cell cycle pro-
gression. Given the requirement of ECD for cell cycle progres-
sion and its direct association with RB (6), we assessed whether
ECD levels or localization are altered during cell cycle progres-
sion. For this purpose, an immortal mammary epithelial cell
line, 76NTERT, was arrested in the G1 cell cycle phase by growth
factor deprivation, and the cells were then allowed to proceed
synchronously though cell cycle phases by culture in regular
growth factor-containing medium. FACS analyses showed that a
majority of growth factor-deprived cells were growth arrested,
with 98% cells in the G1 phase, and only 0.75% cells in the S phase
and 1.25% cells in the G2/M phase (Fig. 1A). Western blotting of
lysates showed no significant differences in the levels of ECD pro-
tein in cells at various times during cell cycle progression (Fig. 1B).
Analysis of nuclear and cytoplasmic fractions prepared at various
times during cell cycle progression showed that ECD localizes pri-
marily in the cytoplasm (Fig. 1C), which is consistent with its
rapid nuclear export, as previously reported (8). Overall, our re-
sults indicate that ECD levels and its subcellular localization do
not change significantly during cell cycle progression.
ECD is phosphorylated on serine residues, but overall phos-
phorylation does not change during cell cycle progression.
Given the known roles of phosphorylation in regulating the cell
cycle machinery (24), we sought to determine whether ECD is a
phosphoprotein and whether its phosphorylation varies with cell
cycle progression. For these analyses, T98G cells (a human brain
glioblastoma cell line that expresses a wild-type RB) (25) were
cultured in low-serum medium for 48 h to induce growth arrest
and then allowed to progress though cell cycle by adding serum-
containing medium with 32P-labeled sodium orthophosphate.
Autoradiography of anti-ECD immunoprecipitates showed that
Mir et al.
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ECD is indeed a phosphoprotein; however, the levels of phosphor-
ylation were comparable at various time points during cell cycle
progression (Fig. 2A). As a control, RB showed an expected cell
cycle-related increase in phosphorylation at the 16- and 20-h time
points (Fig. 2A). Further analyses using anti-FLAG immunopre-
cipitations (IPs) from [32P]orthophosphate-labeled cells express-
ing an exogenous FLAG-tagged ECD protein confirmed the phos-
phorylation of ECD in cells (Fig. 2B). These analyses demonstrate
that ECD is a phosphoprotein; however, the phosphorylation lev-
els do not change during cell cycle progression.
It was reported that a peptide sequence derived from ECDwas
phosphorylated by casein kinase 2 (CK2) in vitro (11). To assess
whether the phosphorylation of ECD corresponds to phosphoser-
ine (p-Ser) or phosphothreonine (p-Thr) residues, anti-FLAG
immunoprecipitates of T98G cells expressing a FLAG-taggedECD
were blotted with anti-p-Ser or anti-p-Thr antibodies. A recom-
binant GST-PERK kinase domain, known to undergo autophos-
phorylation on serine and threonine residues during an in vitro
kinase reaction (26), was used as a positive control for serine and
threonine phosphorylation. Indeed, both p-Ser and p-Thr signals
were detected by blotting of autophosphorylated GST-PERK ki-
nase domain (Fig. 2C). Although no signals were detected with
anti-p-Thr antibody blotting of anti-ECD immunoprecipitation,
even after long exposures, a specific band was observed with the
anti-p-Ser antibody (Fig. 2C). These results suggested that cellular
ECD is predominantly phosphorylated on serine residues.
CK2-mediated phosphorylation of ECD is important for its
cell cycle regulation function. In view of our results presented
above, and a recent study that used an array of spotted peptides to
identify CK2 phosphorylation of an ECD peptide on Ser-505 and
Ser-518 (11), we performed a detailed analysis of potential phos-
phorylation sites on ECD using the publically available Kinase-
Phos 2.0 tool (http://kinasephos2.mbc.nctu.edu.tw/). This analy-
sis identified multiple sites on ECD that could be phosphorylated
by various Ser/Thr kinases. Among these, CK2 was predicted to
preferentially phosphorylatemultiple serine residues, and this was
of obvious interest in view of our results that cellular ECD is pri-
marily phosphorylated on Ser residues (Fig. 2C). The potential
CK2 phosphorylation sites near theC terminus, including Ser-505
and Ser-518 reported in the peptide array screen (11), were pre-
dicted with the highest confidence (Fig. 3A). To directly assess
whether ECD is a CK2 substrate, we performed an in vitro kinase
assaywith purifiedCK2 and recombinant full-length ECDprotein
or its C-terminal truncated versions. Phosphorylation was ob-
served with full-length ECD (residues 1 to 644) and its fragments
encompassing residues 1 to 567 or 1 to 534, whereas substantially
less phosphorylation was observed with the ECD 1-432 fragment
(Fig. 3A and B). These results indicated that ECD was indeed a
substrate for CK2 in vitro and that CK2-dependent phosphoryla-
tion occurs predominantly within the C-terminal region of ECD.
CK2 is known to phosphorylate its substrates in clusters, with
phosphorylation at one site priming the substrate for phosphory-
lation at additional sites (27, 28). The C-terminal region contains
two potential Ser clusters: a proximal cluster of S503, S505, and
S518 and a distal cluster of S572, S579, and S584 (Fig. 3C). To
assess the contribution of these clusters to CK2-dependent phos-
phorylation of ECD, we introduced Ser-to-Ala mutations in these
residues, individually as well as in combinations (Fig. 3C and D).
FIG 1 ECD localization and expression do not change during cell cycle progression. 76NTERT cells were cell cycle arrested by culturing in growth factor-free
DFCI-3 medium for 72 h and then switched to growth factor-containing DFCI-1 medium to initiate cell cycle progression. (A) Cells were fixed in 70% ethanol
at the indicated time points, stained with propidium iodide, and subjected to FACS analysis. (B) Lysates were collected at the indicated time points and subjected
to Western blotting for ECD or -actin. ImageJ software was used to quantify ECD signals at various time points during cell cycle progression and expressed as
relative to -actin signals. (C) Nuclear (N) and cytoplasmic (C) fractions were isolated from cells at various time points during cell cycle progression and
subjected to Western blot analysis with anti-ECD antibody. PARP and GAPDH (glyceraldehyde-3-phosphate dehydrogenase) served as positive controls for
nuclear and cytoplasmic proteins, respectively. All experiments were carried out in triplicate. H.E., higher exposure.
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While S¡A mutations of the Ser residues in the distal cluster
(S572A, S579A, and S584A; designated 3=S/A) had no appreciable
impact on the level of phosphorylation in the in vitro kinase assay,
similar mutations in the proximal cluster (S503A, S505A, and
S518A; designated 3S/A) led to a considerable reduction in the
CK2-mediated phosphorylation (Fig. 3D). Importantly, Ala mu-
tations of all six residues (S503, S505, S518, S572, S579, and S584;
designated 6S/A) nearly completely abolished the CK2-mediated
in vitro phosphorylation of ECD (Fig. 3D). The autoradiography
results were confirmed by subjecting the same filters to blotting
with anti-p-Ser antibody (Fig. 3D). Since we did not observe a
shift in the mobility of the 6S/A mutant on regular SDS-PAGE,
perhaps reflecting a mechanism previously reported by Lee et al.
(29), we performed gel analysis of in vitro-phosphorylated WT,
6S/A, and phosphatase-treated WT ECD after reacting these with
Phos-tag, a dinuclear metal complex that acts as a phosphate-
binding tag and can produce amobility shift (30). As expected, the
Phos-tag-bound WT ECD resolved as a slower-migrating band
compared to its phosphatase-treated sample; notably, the 6S/A
mutant exhibited a faster mobility compared to phosphorylated
WT ECD (Fig. S1A). Collectively, these results show that the C-
terminal Ser clusters of ECD, especially the proximal one, can be
phosphorylated by CK2. The small residual phosphorylation sig-
nal observed with the 6S/A mutant of ECD may reflect an addi-
tional minor site of CK2-mediated phosphorylation.
Although these experiments confirmed and extended the con-
cept of CK2-mediated phosphorylation of ECD in vitro, to relate
this posttranslational modification to ECD function, it was im-
portant to assess whether ECD is phosphorylated in cells on the
same sites and whether such phosphorylation is important for its
function. Thus, we generated pMSCV-puro vector-based retrovi-
ral constructs encoding FLAG-tagged wild type or 3S/A or 6S/A
mutants of ECD. These constructs were expressed in T98G cells,
and cells were metabolically labeled with [32P]orthophosphate.
Equal amounts of radioactive extracts (based on the counts per
minute) were subjected to anti-FLAG IP, followed by autoradiog-
raphy. Although the phosphorylation signal observed with the
3S/A mutant was comparable to that on theWT ECD, the level of
phosphorylation on the 6S/A mutant was markedly reduced (Fig.
3E). To ascertain whether the defective phosphorylation of the
cell-expressed 6S/A mutant reflects simply a lack of phosphoryla-
tion of the distal serine cluster, we compared the levels of phos-
phorylation of FLAG-tagged WT versus 3=S/A mutant by anti-p-
Ser immunoblotting of anti-FLAG IPs of lysates of T98G cells
transfected with the respective constructs.We did not observe any
significant differences in the anti-p-Ser signals of WT ECD versus
its 3=S/A mutant (Fig. S1B). These results establish that the two
serine clusters in ECD identified in vitro as CK2 substrate sites are
the major sites of phosphorylation in cells. Next, T98G cells ex-
pressing FLAG-taggedWT, 3S/A, and 6S/AECDproteinswere left
untreated or treated with a CK2-specific inhibitor TBB and their
anti-FLAG IPs were blotted with anti-p-Ser antibody (Fig. 3F).
Notably, CK2 inhibition reduced the phosphorylation signal in
cells expressing the WT ECD or its 3S/A mutant; however, cells
expressing the 6S/A mutant did not exhibit any change in phos-
phorylation (Fig. 3F), indicating that CK2 is the primary cellular
kinase responsible for the phosphorylation of ECD on two major
serine clusters characterized here. However, it remains possible
that the additional Ser or Thr residues of ECD are phosphorylated
FIG 2 ECD is phosphorylated, predominantly on serine residues. (A) T98G cells were serum-deprived for 48 h, the last 4 h in phosphate-free medium, and then
cultured for indicated times in complete DMEM containing 100 Ci of sodium [32P]orthophosphate per 10-cm plate. ECD or RB (used as a positive control)
were immunoprecipitated, resolved by SDS-PAGE, transferred to a PVDFmembrane, and subjected to autoradiography to detect the phosphorylation signal. (B)
T98G cells transiently transfected to express FLAG-tagged ECDwere cultured for 6 h in phosphate-free DMEM and then metabolically 32P labeled, as described
above. Anti-FLAG IPs were visualized by autoradiography. (C) Anti-FLAG IPs of T98G cells transfected with FLAG-tagged ECD were Western blotted with
anti-p-Ser or anti-p-Thr antibodies. In vitro-phosphorylated GST-PERK kinase domain was used as a positive control for serine and threonine phosphorylation.
The extra band observed in GST-PERK lane is likely a cleavage product of PERK. Arrows point to bands of interest.
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FIG 3 Phosphorylation of ECD is important for its ability to rescue cell cycle arrest in Ecd-null MEFs. (A) Schematic of ECD protein, its C-terminal deleted
constructs, and CK2 phosphorylation sites predicted by the KinasePhos 0.2 tool (http://kinasephos2.mbc.nctu.edu.tw/). (B) ECD is predominantly phosphor-
ylated near its C terminus. In vitro kinase reactions of full-length (aa 1 to 644) ECD and various C-terminal deletion fragments (aa 1 to 567, 1 to 534, and 1 to 432)
with human recombinant CK2 were separated by SDS-PAGE, transferred to PVDF membranes, and subjected to autoradiography to detect 32P signals. The
purity of proteins was assessed by Coomassie brilliant blue staining (CBB). (C) Schematic representation of various point mutants. Black rectangles, WT Ser
residues; white rectangles, mutant Ala residues. (D) CK2 phosphorylates ECD at six sites. His-tagged wild-type ECD or its point mutants were purified by nickel
affinity purification and subjected to an in vitro kinase assay, as described above. 32P labeling was detected using autoradiography, and the filters were
subsequently subjected to Western blotting with anti-p-Ser antibody and reprobed with anti-ECD antibody for equal loading. The purity of recombinant
proteins was assessed by CBB staining. (E) CK2-dependent phosphorylation of ECD at multiple residues in cultured cells. T98G cells expressing FLAG-tagged
ECD or its phosphorylation site mutants 3S/A or 6S/A were metabolically labeled with 32P, as described above. FLAG-tagged ECD and its mutants were
immunoprecipitated and subjected to autoradiography. IP of cells expressing WT ECD subjected to phosphatase treatment is shown. The blot was reprobed
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by other kinases, depending on the cell type or varying functional
states.
Next, we assessed whether the phosphorylation of ECD on
CK2-dependent serine clusters is relevant to its cell cycle regula-
tory function. We have previously demonstrated that introduc-
tion of Cre recombinase in Ecdfl/fl MEFs, using adenovirus Cre,
causes G1 cell cycle arrest that is largely rescued by introducing
human ECD (6). We used this approach to compare the extent of
the rescue of cell cycle arrest induced by endogenous ECD dele-
tion upon introducing the wild-type ECD or its phosphodefective
mutants. In initial experiments, we expressed the WT human
ECD or its 3S/A or 6S/A mutants in Ecdfl/fl MEFs (Fig. 3G) and
then assessed the ability of the cells to progress through cell cycle
without or with Cre-induced Ecd deletion. In each case, the ex-
pression of exogenous human ECD proteins and the depletion of
endogenous mouse ECD were confirmed by Western blotting
(Fig. 3G). As expected, the deletion of Ecd in Ecdfl/flMEFs arrested
proliferation with no recovery during the entire observation pe-
riod (Fig. 3H), and ectopicWT ECD significantly rescued the cells
from growth arrest (Fig. 3H; also see Fig. S2A in the supplemental
material). Notably, while the 3S/Amutant behaved comparably to
WT ECD in rescuing cells from growth arrest, the 6S/A mutant
only exhibited a partial rescue in comparison to that seenwithWT
ECD in repeated experiments (P	 0.001) (Fig. 3H) (all P values
are shown in Table S1 in the supplemental material). Further-
more, we examined a mutant in which serine residues 503, 505,
and 518 were removed by deletion (
499–527) in the cell cycle
rescue experiment and observed that this mutant behaved simi-
larly to WT ECD in rescuing the proliferation block (see Fig. S2A
and B in the supplemental material). Next, we generated a phos-
phomimetic mutant in which the six serine residues identified to
be phosphorylated were mutated to aspartic acid residues (6S/D).
Notably, the phosphomimeticmutant 6S/Dwas completely defec-
tive in cell cycle rescue experiment (Fig. 3I and J). In these exper-
iments, we also examined the 3=S/Amutant and observed a partial
rescue with this mutant (Fig. 3J). Although the complete lack of
rescue seen with the 6S/D mutant of ECD was surprising, it has
been reported that aspartic acid phosphomimics are unsuitable
for biological readouts due to different chemical properties of the
two residues (31, 32). Taken together, our results underscore the
importance of ECD phosphorylation for cell cycle progression.
Phosphodefective ECDmutants retain their ability to inter-
act with PIH1D1 protein, as well as with other components of
the R2TP complex. In view of the complete lack of any functional
impact of mutating ECD on S503/505/518 residues, we first reex-
amined the previously reported dependence of ECD binding to
the isolated phospho-reader domain of PIH1D1 (11). For this
purpose, GST-PIH1D1 pulldown was carried out with lysates of
HEK-293T cells transiently transfected to express WT ECD or its
3S/A and 6S/A mutants. Confirming previous findings (11), WT
ECD, but not its 3S/A or 6S/A mutant, was pulled down with
GST-PIH1D1 (Fig. 4A). These results suggested that either the
R2TP association was unnecessary for ECD function in cell cycle
progression or an alternate mechanism may recruit ECD to the
R2TP complex. To distinguish between these possibilities, we first
carried out anti-ECD IPs of U2OS and MEF cell lysates, followed
by anti-PIH1D1 blotting. These analyses confirmed the interac-
tion of endogenous ECD and PIH1D1 (Fig. 4B and C). To exam-
ine the nature of ECD/PIH1D1 interaction in cells, we carried out
anti-PIH1D1 immunoprecipitations from HEK-293T cells ex-
pressing untagged (Fig. 4D) or GFP-tagged ECD (Fig. 4E; see also
Fig. S3A in the supplemental material), WT ECD or its phosphor-
ylation site mutants (defective in binding to PIH1D1 in the pull-
down assay), followed by blotting for ECD (Fig. 4D) or GFP (Fig.
4E, see also Fig. S3A in the supplemental material), as well as for
the four R2TP complex components (Fig. 4D and E; see also Fig.
S3A in the supplemental material). Since a phosphorylated
DSpDD/Emotif, conserved between human andmouse ECDpro-
teins (Fig. 4F), was previously found to promote the interaction of
ECDwith PIH1D1 in vitro (11), we also examined a deletion con-
struct (
499–527) of ECD that lacks the DSDD/E motif in ad-
dition to the S6/A mutant lacking all CK2-phosphorylated
sites. As expected, PIH1D1 IPs were able to co-IP RPAP3,
RUVBL1, or RUVBL2 to a similar extent in all lanes (Fig. 4D
and E). Notably, compared to the levels of endogenous ECD co-IP
with PIH1D1 in vector control lanes, increased amounts of ectop-
ically expressed ECD were coimmunoprecipitated from WT
ECD-transfected cell lysates. Unexpectedly, however, theWT and
mutant ECD proteins were coimmunoprecipitated with PIH1D1
to comparable levels (Fig. 4D and E; see also Fig. S3A in the sup-
plementalmaterial). These results demonstrate that ECD interacts
with the R2TP complex in cells but that the phosphorylation-
dependent interaction of ECDwith PIH1D1 is dispensable for this
association. In further support of this conclusion, we carried out
anti-ECD and anti-PIH1D1 IPs, treated these IPs with lambda
phosphatase, and then assessed the levels of coimmunoprecipi-
tated PIH1D1. Notably, although the phosphatase treatment ro-
bustly eliminated the phosphorylation signal on ECD (anti-p-Ser
blot), no reduction in PIH1D1or ECD coimmunoprecipitation
was seen (see Fig. S3B and C in the supplemental material). Thus,
while CK2-phosphorylated ECD can directly interact with
PIH1D1, as reported previously (11), this interaction is not re-
quired for the association of ECD with the R2TP complex. Next,
we examined the ability of 6S/D or 3=S/A mutants of ECD to
interact with PIH1D1. For this purpose, lysates from 293T cells
expressing FLAG-tagged 3=S/A or 6S/D mutants were used for an
in vitro pulldown assay with GST-PIH1D1. As expected, GST-
PIH1D1 was able to pull down the 3=S/Amutant but failed to pull
with anti-ECD antibody for equal IP loading. (F) Inhibition of CK2 reduces ECD phosphorylation. T98G cells expressing FLAG-tagged ECD or its phosphor-
ylation site mutants 3S/A and 6S/A were treated with CK2 inhibitor TBB (50 M) for 4 h, subjected to anti-FLAG IP, and Western blotted with anti-p-Ser or
anti-FLAG antibodies. The intensity of anti-p-Ser signals was quantified using ImageJ software and normalized relative to FLAG-ECD signals. (G) Phosphory-
lation of ECD at six CK2 sites is important for its cell cycle progression function. Ecdflox/flox MEFs stably expressing vector control, wild-type human ECD, or its
indicated mutants were infected with control (ctrl) adeno-GFP or adeno-GFP-Cre (cre) viruses for the indicated times, and lysates were analyzed by anti-ECD
and -tubulin (loading control). Note that human ECD-reconstituted cells express both endogenous mouse (mEcd higher band) and ectopic hECD or its
mutants (hECD, lower band). (H to J) Analysis of hECD or its mutants for rescue of Ecdfl/fl MEFs from cell cycle arrest induced by Cre-mediated Ecd deletion.
Ecdfl/fl MEFs expressing vector (V), WT hECD or its 3S/A, 6S/A, 6S/D or 3=S/A mutants were infected with control (ctrl) or Cre adenoviruses, followed by cell
counting at the indicated time points. The Cre/Ctrl cell number ratios at each time point were plotted to assess the level of rescue relative to vector-expressing
MEFs. Simulation’s correction was applied to control for multiple testing in the calculation of the mean ratio. The experiment is representative of three repeats.
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down the 6S/D mutant of ECD (see Fig. S3D in the supplemental
material), confirming that 6S/D does not mimic WT ECD for its
interaction with PIH1D1.
Novel phosphoindependent interaction of ECD with R2TP
complex through RUVBL1. Since disabling ECD binding to
PIH1D1 in the 3S/A mutant had no impact on ECD association
with the R2TP complex in cells or on ECD function during cell
cycle progression, we used an unbiased approach to identify po-
tential mediators of ECD’s interaction with the R2TP complex.
We used an in vitro tandem affinity purification approach (23) to
identify ECD interacting partners. For this purpose, full-length
ECD was tagged with GST on the N terminus and with FLAG
epitope on the C terminus, and the twin-tagged recombinant pro-
tein was prepared in a glutathione-Sepharose bead-bound form.
Cell lysates prepared from 76NTERT cells were incubated with
these beads, and proteins in the complex were eluted by cleaving
the ECD-FLAG part of the GST-ECD-FLAG fusion on beads with
PreScission protease. The eluted ECD-FLAG, in complexwith cel-
lular proteins, was subjected to a second round of affinity purifi-
cation using anti-FLAG antibody beads, and the protein com-
plexes were eluted with a FLAG epitope peptide. The proteins in
the complex were separated by SDS-PAGE and visualized by silver
staining (Fig. 5A), and bands only seen in lanes where recombi-
nant protein was incubated with cell lysates were excised and sub-
jected to mass spectrometry. Proteins with Mascot scores of50
were considered potential interacting partners.
These analyses identified a knownECDbinding partner PRPF8
(7) and in addition revealed several new binding partners. Inter-
action of PRPF8 with ECD was confirmed by immunoprecipita-
FIG 4 ECD phosphorylation in living cells is dispensable for its interaction with PIH1D1 and other components of the R2TP complex. (A) In vitro interaction
of GST-PIH1D1 with ECD and its mutants. GST-PIH1D1 was immobilized on glutathione-Sepharose beads and incubated with lysates of HEK-293 cells
expressing FLAG-tagged WT ECD or its 3S/A or 6S/A mutant. (B and C) Interaction between endogenous ECD and PIH1D1 was confirmed by immunopre-
cipitation of ECD fromU2OSorMEFs, followed byWestern blottingwith anti-PIH1D1 antibody. (D andE) Lysates ofHEK-293T cells transfectedwith untagged
(D) or GFP-tagged (E) WT, 3S/A, 6S/A, or 
499–527 ECD were subjected to immunoprecipitation with anti-PIH1D1 antibody and immunoblotted with the
indicated antibodies. (F) Alignment of mouse and human ECD sequences in the region containing the DSDD/E motif. V, vector-transfected cells.
FIG 5 ECD interacts with RUVBL1. (A) Tandem affinity purification identi-
fied RUVBL1 as an ECD-interacting protein. 76NTERT cell lysates were incu-
bated with glutathione-Sepharose bead-bound GST-ECD-FLAG and protein
complexes eluted by cleaving the ECD-FLAG portion with PreScission pro-
tease. Eluted ECD-FLAG in complex with bound proteins was further affinity
purified using FLAG beads and then eluted using excess FLAG peptide. The
presented gel corresponds to 5% of the final eluates visualized by silver stain-
ing. Arrows point to the gel slices that were analyzed by mass spectrometry.
The top andmiddle arrows point to slices that identified PRPF8 and RUVBL1,
respectively. (B) Interaction between endogenous RUVBL1 and ECD. Lysates
of HEK-293T cells expressing FLAG-taggedWT ECD or its 6S/A mutant were
subjected for anti-RUVBL1 IP, followed by anti-FLAG blotting. (C) PIH1D1
knockdown does not affect RUVBL1-ECD association. Lysates of U2OS cells
transfected with PIH1D1 or scrambled control siRNA 48 h earlier were sub-
jected to anti-ECD IP followed by blotting with antibodies against the indi-
cated proteins. V, vector-transfected cells.
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tion (see Fig. S3E in the supplemental material). Among the new
partners, RUVBL1 was one of the top candidate proteins with a
Mascot score of 168. To validate the purification results, we ex-
pressed the FLAG-tagged WT ECD or its 6S/A mutant in 293T
cells and performed coimmunoprecipitation experiments with an
anti-RUVBL1 antibody. Both theWT and the 6S/A ECD proteins
were coimmunoprecipitated with RUVBL1, suggesting that ECD
interacts with RUVBL1 and that this interaction is independent of
ECD phosphorylation (Fig. 5B). To further establish that ECD-
RUVBL1 interaction is independent of PIH1D1, we knocked
down the endogenous PIH1D1 with siRNA and then performed a
co-IP experiment using an anti-ECD antibody. Notably, we ob-
served equal co-IP of RUVBL1 in both control and PIH1D1
knockdown cells, confirming that ECD interaction with RUVBL1
is PIH1D1 independent (Fig. 5C). Taken together, these results
demonstrate that ECDassociateswith theR2TP complex though a
novel interaction with RUVBL1, independent of ECD’s interac-
tion with PIH1D1.
InteractionwithRUVBL1 is important for the role of ECD in
cell cycle progression. Germ line deletion of Ecd or Ruvbl1 is
embryonic lethal (6, 18), and silencing of either protein in cells
leads to cell cycle arrest (6, 17, 18), suggesting that interaction of
ECD with RUVBL1 may play a role in the cell cycle regulation
function of ECD. To test this hypothesis, we first expressed GFP-
tagged ECDor its several C-terminal deletionmutants inHEK-293T
cells and performed co-IP experiments using an anti-RUVBL1 anti-
body. Notably, only full-length ECD protein (amino acids [aa] 1 to
644) coimmunoprecipitated with RUVBL1, whereas none of the C-
terminal deletions of ECD was able to coimmunoprecipitate with
RUVBL1 (see Fig. S4A and B in the supplemental material). To
validate these results, we constructed several GST-tagged andHis-
tagged ECD deletion fragments based on the predicted secondary
structure (by Garnier Robson predictions and PONDR VL-XT
secondary structure prediction) and then examined the direct in-
teraction of these ECD mutant proteins with FLAG-RUVBL1 or
endogenous RUVBL1 using pulldown with glutathione-Sephar-
ose or nickel beads. As shown in (Fig. 6A andB; see also Fig. S4C in
the supplemental material), only the full-length ECD interacts
with RUVBL1, whereas all C-terminal or N-terminal deletions
rendered ECD defective in binding to RUVBL1. Next, we com-
pared various FLAG-tagged deletion fragments of ECD (residues
150 to 438, 438 to 644, 1 to 438, and 150 to 644) (see Fig. S4D in the
supplementalmaterial)withwild-type ECD(residues 1 to 644) for
their abilities to rescue the growth arrest of Ecdfl/fl MEFs upon
adeno-Cre-mediated endogenous Ecd deletion by analyzing cell
proliferation by cell counting or colony formation (Fig. 6D). In
each case, the expression of exogenous human ECD proteins and
loss of expression of endogenous mouse Ecd in Cre-expressing
cells was confirmed using Western blotting (Fig. 6C; see also Fig.
S4D in the supplemental material). As expected, deletion of Ecd in
Ecdfl/fl MEFs arrested cell proliferation, and ectopic WT human
ECD significantly rescued the cells from growth arrest (Fig. 6D).
However, none of the deletion mutants was able to rescue the cell
proliferation block imposed by endogenous ECDdepletion. These
FIG 6 Interaction with RUVBL1 is important for ECD function in cell cycle progression. (A and B) Interaction between FLAG-RUVBL1 and ECD. GST-tagged
or His-tagged full-length ECD or its truncated mutants immobilized on glutathione-Sepharose or nickel beads, respectively, were incubated with lysates of
HEK-293T cells expressing FLAG-tagged RUVBL1. (C)Western blotting to show the expression ofWT human ECD or its deletionmutants in Ecdfl/flMEFs with
control or Cre adenovirus infection (arrowheads point to the human ECD or mutants). Also note that anti-ECD antibody blot does not detect the C-terminally
deleted ECD 1-438 mutant. (D) Colony formation assay. Ecdfl/fl MEFs expressing full-length WT ECD (aa 1 to 644) or its truncations were infected with ctrl or
Cre adenoviruses, colonies were stained with crystal violet after 10 days, and the solubilized dye absorbance was read at 590 nm. A histogram shows the relative
rescue efficiency of each construct compared to vector control cells. Error bars represent themeans the standard deviations of three independent experiments.
A statistical comparison used a Student two-tailed t test. (E) Interaction of FLAG-tagged ECD or its deletion fragments with PIH1D1. Lysates of HEK-293T cells
expressing the indicated FLAG-tagged ECD fragments were used for GST-PIH1D1 pulldown, followed by anti-FLAG blotting. V, vector-transfected cells.
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results demonstrate that only the full-length ECD, which interacts
with RUVBL1, supports cell cycle progression. The lack of rescue
with ECD deletion fragments was not due to lack of their expres-
sion (Fig. 6C; see also Fig. S4D in the supplemental material).
Notably, two deletion fragments (residues 438 to 644 and 150 to
644) that failed to rescue cell cycle arrest still retained their ability to
interact with PIH1D1 (Fig. 6E), further underscoring the conclusion
that interaction of ECD with PIH1D1 is dispensable, while its inter-
action with RUVBL1 is indispensable for a role in cell cycle progres-
sion. PIH1D1 is known to directly interactwith other components of
the R2TP complex, such as RUVBL1 (33). Reprobing of the same
membrane with antibodies against RUVBL1 and RUVBL2 showed
the expected interaction of PIH1D1with RUVBL1 or RUVBL2 (see
Fig. S4E in the supplemental material).
Our previous studies showed that ECD interacts with RB, a
function important for the ECD role in cell cycle progression (6).
Notably, in addition to the expected interaction of full-length
ECD with RB, one mutant (aa 150 to 644) that is defective in
rescuing cell cycle arrest (Fig. 6D) was earlier shown to retain its
ability to interact with RB (6), suggesting that interaction with
RUVBL1 is required for ECD to promote cell cycle progression
while interaction with RB in the absence of interaction with
RUVBL1 is insufficient for this function. In further support of
this conclusion cell cycle function competent (3S/A) and deficient
mutant (6S/A) of ECD show comparable interaction with RB (see
Fig. S4F in the supplemental material).
Ecd deletion leads to reduced mitotic index and delayed mi-
totic progression. We have previously reported that the prolifer-
ation arrest upon Ecd deletion is not associated with any increase
in apoptosis (6). To examine the effect of Ecd deletion on mitosis,
we used adeno-Cre to delete Ecd in Ecdfl/flMEFs andmeasured the
MFI of phospho-histone H3 (S10) as an indicator of the propor-
tion of cells inmitosis using flow cytometry (34). Ecd-deleted cells
showed a marked decrease in the MFI (45.7) of pH 3 (S10) com-
pared to control cells (89.8) (Fig. 7A), indicating that Ecd deletion
cells are cell cycle arrested prior to entering mitosis. Low levels of
pH 3 (S10) were further confirmed byWestern blotting (Fig. 7B).
Next, we assessed the G2/M to G1 progression of MEFs arrested in
the S phase by nocodazole treatment (Fig. 7C). Flow cytometry
analysis revealed a significant impairment in G2/M-to-G1-phase
transition upon Ecd deletion compared to control, in addition to a
higher percentage of Ecd-deletedMEFs in the G1 phase (Fig. 7C to
E). Taken together, these results demonstrate a critical role of ECD
in both G1-to-S and G2/M-to-G1 transitions. These results are
consistent with the known function of CK2 and RUVBL1 in cell
cycle regulation (35–37).
DISCUSSION
Precise regulation of the entry into, progression through, and exit
from the cell cycle is fundamental to developmental programs and
maintenance of adult tissues in multicellular organisms. Notably,
components of the cell cycle machinery and the pathways that
regulate their functions are commonly altered in cancer and other
diseases (1). Thus, elucidating how the cell cycle machinery is
controlled is an important area of research in cell and cancer bi-
ology.
We have previously shown that ECD, the mammalian ortho-
logue of Drosophila ecdysoneless gene, is required for embryonic
development and progression of mammalian cells through the
G1-S phase of cell cycle progression (6). Here, we identify a novel
FIG 7 Ecd deletion leads to a mitotic block. (A) Ecdflox/flox MEFs infected with control (blue) or Cre adenoviruses (red) were fixed in 70% ethanol, stained with
anti-pH3(S10), and analyzed by flow cytometry. The median fluorescence intensity (MFI), representing the peak channel number on the x axis, is shown. (B)
Lysates of control (Ctrl) or Ecd-deleted (Cre) Ecdflox/flox MEFs were blotted with the indicated antibodies. (C) Control (Ctrl) or Ecd deletion (Cre) MEFs were
treated with 100 ng of nocodazole/ml for 20 h, and cells were switched to nocodazole-free medium to initiate cell cycle progression for the indicated time points.
The cells were stained with propidium iodide and analyzed by FACS for cell cycle analysis. (D) A graph shows the percentage of cells entering the G1 phase after
release fromnocodazole treatment at various time points. Data points aremeans the standard deviations of results from three independent experiments (*,P
0.05, as determined by two-tailed Student t test). (E) The deletion of Ecd in the experiment shown in panel C was confirmed by Western blotting.
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mechanism by which ECD functions as an essential element of
mammalian cell cycle progression. Using multiple complemen-
tary approaches, we demonstrate a novel interaction of ECD with
the R2TP chaperone complex, mediated by the RUVBL1 compo-
nent of R2TP, which we establish is required for ECD to promote
cell cycle progression. We also identify a role for the CK2-depen-
dent phosphorylation of ECD in cell cycle progression. In contrast
to predictions from a previous study (11), this role is independent
of the ECD interaction with PIH1D1, the phospho-reader com-
ponent of the R2TP complex.
Our findings establish that the phosphorylation of ECD posi-
tively regulates its function in promoting the cell cycle progres-
sion. Bioinformatics analysis, followed by mass spectroscopy-
based phosphoproteomics, identified a number of sites that could
be phosphorylated by cellular kinases, but we focused on two clus-
ters of potential CK2 phosphorylated serine residues since a recent
study (11) showed that CK2-mediated phosphorylation of two
such serine residues in the context of a peptide created a binding
site for the phospho-reader subunit of the R2TP complex. CK2-
dependent phosphorylation of site-directed mutants of ECD in
vitro and in cultured cells identified six serine residues in two
spatially separated clusters to be the major CK2 phosphorylation
sites on ECD. Notably, however, ECD phosphorylation does not
change during cell cycle progression. This is not entirely surpris-
ing since our in vitro analyses, aswell as phosphorylation studies in
cells in the presence of a CK2 inhibitor (Fig. 3D and F), establish
that CK2 is the predominant kinase that phosphorylates ECD;
CK2 is considered to be constitutively active and ubiquitous ser-
ine/threonine protein kinase (38). Despite its constitutive activity,
however, numerous studies point to a role for CK2 in cell prolif-
eration and survival (39). Yet, the molecular pathways that medi-
ate the function of CK2 in cell proliferation are largely unknown.
We suggest that phosphorylation of ECD by CK2 provides one
mechanism for CK2’s role in cell proliferation. Although the over-
all levels and the subcellular localization of ECD remain invariant
during cell cycle progression (Fig. 1 and 2), it remains possible that
ECD phosphorylation at specific sites may vary during cell cycle
progression. As phospho-specific antibodies against specific ser-
ine residues on ECD become available, it should be feasible to test
this notion further.
Our findings that ECD is indeed a CK2 substrate in vitro (Fig.
3) suggested that CK2-dependent phosphorylation and subse-
quent interaction of ECDwith the R2TP complex could provide a
potential mechanism by which ECD could promote the cell cycle
transit. Our co-IP studies in cell cultures demonstrate that ECD in
fact is in a complex that includes the four core subunits of the
R2TP complex (Fig. 4D and E). Remarkably, however, multiple
mutant ECD proteins, rendered incapable of directly interacting
with PIH1D1, includingmutations of critical serine residues in the
3S/A mutant or the 6S/A mutant or deletion of the region incor-
porating the major CK2 phosphorylation sites and the acidic mo-
tif DSDD that facilitates PIH1D1 interaction (11), fully retained
the ability to associate with the R2TP complex. Furthermore, the
ECD-R2TP association was retained in PIH1D1-depleted cells
(Fig. 5C). Thus, our results support a PIH1D1-independent
mechanism of ECD association with the R2TP complex. Impor-
tantly, S¡Amutation of ECD residues that impart PIH1D1 bind-
ing (3S/A and 
499–527) had no impact on its ability to function
in cell cycle progression. However, 6S/A and 6S/D were defective
in a cell cycle rescue experiment, underscoring the importance of
ECD phosphorylation for its function that encompasses amino
acids beyond PIH1D1 interaction. Thus, the role of phosphoryla-
tion in regulating ECD function during cell cycle appears to be
independent ofmediating an interactionwith PIH1D1. It remains
possible, however, that phosphorylation-dependent interaction of
ECD with PIH1D1, and consequently with the R2TP complex, is
required for other functions of ECD aside from its role in promot-
ing cell cycle progression (6). We have shown that ECD overex-
pression in cells leads to p53 stabilization and increased p53-de-
pendent target gene expression and to the induction of a
senescence phenotype in primary fibroblasts (5). ECD was also
found to interact with thioredoxin-interacting protein (TXNIP),
which was shown to promote p53 stabilization (40). TXNIP has a
number of other functions, including the regulation of glucose
uptake, oxidative stress, and endoplasmic reticulum stress-in-
duced apoptosis (41, 42), Thus, ECD phosphorylation and inter-
action with PIH1D1may play a role in regulating these functions.
The availability of Ecdfl/flMEFs inwhich ECD can be conditionally
deleted, togetherwith the phosphorylation-defectivemutants that
we have characterized here, should allow these notions to be tested
in the future.
In view of a novel, PIH1D1-independent mechanism of ECD
association with the R2TP complex, we sought to answer two key
mechanistic questions: first, what are the determinants of ECD-
R2TP association, and second, whether this unique mode of in-
teraction is functionally relevant in the context of cell cycle pro-
gression role of ECD. Unbiased proteomics analysis of cellular
proteins that interacted with a recombinant full-length ECD pro-
tein, followed by biochemical analyses in cells, demonstrated that
ECD interacts with another component of the R2TP complex,
RUVBL1 (Fig. 5 and 6). Structure-function studies of ECD using
deletion fragments demonstrated a strong correlation between the
cell cycle progression function of ECD and its ability to interact
with RUVBL1, with only the full-length ECD competent at both
functions (Fig. 6A and B; see also Fig. S4B and C in the supple-
mental material). Interestingly, the 
499–527 mutant which in-
teracts with RUVBL1, but not PIH1D1, was able to rescue the cell
cycle arrest caused by Ecd deletion (see Fig. S2A in the supplemen-
talmaterial). Thus, our studies identify a novel interaction of ECD
with RUVBL1 and suggest that this mode of interaction with the
R2TP complex is a key to the regulation of cell cycle progression by
ECD. The delineation of sequences in ECD and RUVBL1 that
mediate their interaction should help directly test whether selec-
tive abrogation of this interaction is functionally critical in cell
cycle progression, as well as to assess the potential role of ECD in
other roles of RUVBL1 within the R2TP complex. Interestingly,
mouse ECD and RUVBL1 knockouts are phenotypically similar,
since both are embryonic lethal at the blastocyst stage (6, 19).
RUVBL1 is essential for cellular proliferation as seen in knockout
cells or upon knockdown of RUVBL1 expression (18). A recent
study demonstrated that RUVBL1 functions as a critical factor for
p300 recruitment to OCT4 target genes (18). It is of interest that
ECD also interacts with p300 and promotes its transcriptional
coactivator function (8). Thus, ECD may function in close coor-
dination with RUVBL1.
Given the evidence we present that ECD can physically interact
with two distinct components of the R2TP complex, it is conceiv-
able that certain ECD functions require both modes of interac-
tion. Recent studies have shown that, aside from the R2TP com-
plex, RUVBL1/2 are also parts of other functionally relevant
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complexes, such as chromatin remodeling complexes TIP60,
SWR/SRCAP, and INO80 and the Fanconi anemia core complex
that controls DNA interstrand cross-link repair and function, and
regulate telomerase biogenesis and mitosis (19, 43–45). Given the
PIH1D1-independent interaction of ECD with RUVBL1, the po-
tential roles of ECD via these alternative complexes will be of great
future interest.
An essential role of ECD in cell cycle progression was estab-
lished by our previous observation that ECD is essential for em-
bryogenesis and its conditional deletion in MEFs leads to a G1-S
cell cycle arrest, together with an inability to initiate an E2F-de-
pendent transcriptional program essential for cell cycle progres-
sion (6). Notably, we demonstrated that ECD competes with E2F
for binding to the pocket domain of RB and that the cell cycle
progression defect in Ecd-null MEFs could be overcome by re-
moving theRB-mediated suppression of E2F using a pocket-bind-
ing oncogene HPV16 E7. Since a key mechanism by which the
R2TP complex regulates biochemical processes is by facilitating
protein complex remodeling, we speculate that the interaction of
ECD with the R2TP complex through RUVBL1 may facilitate the
ECD-RB complex formation and helps dissociate RB from E2Fs,
thereby derepressing the E2F-mediated transcription and pro-
moting cell cycle progression. Consistent with this speculative
model, our previous studies showed that binding to RB was not
sufficient for the cell cycle progression function of ECD, since we
identified one ECD mutant that was able to interact with RB but
was defective in cell cycle rescue.
Our previous studies demonstrated that ECD is overexpressed
in breast and pancreatic cancer patient tissues and that ECD
overexpression correlates with poor prognosis and poor sur-
vival in breast cancer patients (9, 10). It is noteworthy that
several components of the R2TP/prefoldin complex, including
PIH1D1, RUVBL1, and RUVBL2, are also overexpressed in
various cancers and are predicted to play important roles in on-
cogenesis (46, 47). A comprehensive meta-analysis of The Cancer
Genome Atlas (TCGA) data sets (46) revealed that expression of
many RUVBL complex genes was significantly higher in breast
and colorectal carcinomas compared to their normal tissue
controls. These investigations suggested a correlation between
RUVBL complex component overexpression and increased
mTORC1 signaling and metabolic processes necessary for tumor
cell growth (46). Another study demonstrated that PIH1D1 is
overexpressed in various breast cancer cell lines, where it plays a
major role in rRNA transcription (48). Our recent studies showed
a co-oncogenic role of ECD with Ras when introduced into im-
mortal human mammary epithelial cells (49), further suggesting
the potential collaborative role of ECD and the R2TP or other
RUVBL-containing complexes in cell cycle regulation and onco-
genesis.
A positive role of ECD in pre-mRNA splicing was reported
recently based on rescue of splicing defects in the prothoracic
glands of Ecd-deficient flies by human ECD and interaction of
ECD with a complex containing the spliceosome component
PRP8 (7, 50). Our affinity purification/mass spectrometry analy-
ses confirmed the interaction of ECD with PRPF8. The R2TP
complex regulates mRNA and ribosome biogenesis by facilitating
the assembly of small nucleolar ribonucleoproteins (snoRNPs),
which are known to be involved in spliceosome modification (51,
52).Upregulation of R2TP and snoRNP components is thought to
promote ribosome synthesis in cancer cells (47).Whether overex-
pressed ECD in tumors may function in concert with R2TP and
other RUVBL1-containing complexes to promote oncogenesis re-
quires further investigation. Taken together, the findings pre-
sented here demonstrate thatCK2-mediated phosphorylation and
interaction with RUVBL1 are essential for ECD’s ability to regu-
late cell cycle progression.
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